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resumo 
 
 
Com o aparecimento de microrganismos resistentes a antibióticos, de 
doenças que não respondem a terapias comuns recorrendo a fármacos e 
de indivíduos que são incapazes de responder ao método de vacinação 
tradicional, hoje em dia, é de grande preocupação para a sociedade 
humana, o desenvolvimento de anticorpos específicos com aplicação em 
imunoterapia passiva. Apesar de os anticorpos de mamíferos serem mais 
específicos, os anticorpos obtidos a partir de gema de ovo de galinhas 
imunizadas, imunoglobulina Y (IgY), são uma alternativa possível onde a 
quantidade de anticorpos obtida é maior e recorrendo ainda a métodos não 
invasivos. Esta grande quantidade disponível de anticorpos permite 
explorar um novo tipo de biofármacos menos dispendiosos que os 
convencionais. No entanto, o custo da produção de IgY com elevado grau 
de pureza continua a ser mais elevado do que o de outras terapias 
convencionais devido à falta de uma técnica de purificação eficiente. Assim, 
neste trabalho, estudaram-se três tipos de sistemas aquosos bifásicos 
(SAB) constituídos, nomeadamente, por polímeros e Na2SO4, por 
polímeros, Na2SO4 e líquidos iónicos (LIs) como adjuvantes, e por Na2SO4 
e LIs, como uma técnica de extração e purificação alternativa para o IgY a 
partir da gema de ovo. De acordo com os resultados obtidos pode-se 
constatar que a purificação do IgY não foi conseguida num único passo de 
extração (sendo a β-livetina o maior contaminante encontrado). No entanto, 
e dos resultados conseguidos, mostrou-se que os SAB utilizando LIs como 
adjuvantes permitem uma extração seletiva da β-livetina para uma das 
fases e será possível purificar a imunoglobulina ao aplicar extrações 
sucessivas. De entre os vários SAB avaliados, os que permitiram melhores 
resultados em termos de extração seletiva e posterior purificação do IgY 
são constituídos por polietilenoglicol (PEG) com uma baixa massa 
molecular e por LIs com o anião dicianamida.  
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abstract 
 
With the emergence of antibiotic-resistant microorganisms, diseases that are 
unresponsive to drug therapy, and the appearance of individuals that are 
unable to respond to conventional vaccines, the development of antigen-
specific antibodies for use in passive immunotherapy is, nowadays, a major 
concern in human society. Despite the most focused mammal antibodies, 
antibodies obtained from egg yolk of immunized hens, immunoglobulin Y (IgY), 
are an alternative option that can be obtained in higher titres by non-stressful 
and non-invasive methods. This large amount of available antibodies opens the 
door for a new kind of cheaper biopharmaceuticals. Nevertheless, the 
production cost of high-quality and/or high-purity IgY still remains higher than 
other drug therapies due to the lack of an efficient purification method. 
Therefore, in this work, three types of aqueous two-phase systems (ATPS) 
were studied constituted by polymers and Na2SO4, polymers, Na2SO4 and ionic 
liquids (ILs) as adjuvants and by Na2SO4 and ILs, as an alternative technique 
for the selective extraction, and thus purification, of IgY from egg yolk. 
According to the obtained results, the complete purification of IgY was not 
achieved in a single step procedure (with β-livetin being the major contaminant 
found). However, the results obtained reveal that ATPS using ILs as adjuvants 
allow the selective extraction of β-livetin for one phase and it is possible to 
purify the immunoglobulin if successive extractions are applied. Amongst the 
various ATPS evaluated, the improved results on the selective extraction and 
subsequent purification of IgY were obtained with ATPS consisting of 
polyethylene glycol (PEG) of low molecular mass and ILs with the anion 
dicyanamide. 
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1.1.  Scopes and objectives 
The emergence of drug-resistant microorganisms, diseases that are unresponsive to 
drug therapy and the appearance of individuals with impaired immune systems who are 
unable to respond to conventional vaccines make the search of effective alternative 
therapeutics a crucial goal to be achieved within the next few years [1]. 
Biopharmaceuticals have greatly improved the treatment of many diseases and sometimes 
are the only approved therapies available for a particular disease. These biological-based 
products, including recombinant therapeutic proteins, antibody-based products for in vivo 
medical purposes and nucleic-acid-based products have shown application in several 
medicinal areas such as vaccination, immunization and oncology, and autoimmune, 
cardiovascular, inflammatory and neurological diseases [2].  
In the past 10 years an increase of the commercial potential of antibodies as major 
therapeutic drugs has been observed. The ability of antibodies to bind an antigen with a 
high degree of affinity and specificity has led to their ubiquitous use in a variety of 
scientific and medicinal disciplines [3]. However, the production cost of high-quality 
antibodies, and in particular of immunoglobulin Y (IgY, hen antibody), still remains higher 
than other drug therapies due to the absence of a cost-effective purification method. 
Despite the advantages of IgY over mammal antibodies, only less than 2 % of the total 
polyclonal antibodies produced worldwide are IgY. This low percentage is due to the 
difficulties in isolating antibodies from egg yolk, which is fundamentally composed of 
lipoproteins [4]. 
The main objective of this work is the development of an alternative purification 
platform for the selective extraction, and thus purification, of IgY from egg yolk using 
aqueous two-phase systems (ATPS). The use of ATPS for the selective extraction of 
mammal antibodies was previously addressed using conventional polymer-polymer or 
polymer-salt combinations [5-8]. Typical polymer-based ATPS display two hydrophobic 
phases, or a hydrophobic polymer-rich phase and a highly hydrophilic and ionic salt-rich 
phase. Therefore, there is always a restricted polarity difference between the two phases 
which has limited their success in the selective extraction and purification of monoclonal 
antibodies from complex matrices [7]. On the other hand, for the purification of IgY, a 
much less studied class of antibodies, only one work using micelle-based ATPS composed 
of a phosphate salt and Triton X-100 was found [9]. Previous literature results have 
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confirmed the enhanced ability of IL-based ATPS to separate and purify target 
biomolecules from complex matrices [10-17]. The major reason behind such improved 
capability relays on the possibility of tailoring the phases’ polarities and affinities by a 
proper choice of the IL which constitutes a given ATPS. Indeed, there are circa one million 
of different ILs that can be synthesized [18]. Therefore, in this work, several ATPS were 
studied to infer on their potentiality to purify IgY from egg yolk, and composed of 
polyethylene glycol and Na2SO4; polyethylene glycol, Na2SO4 and ionic liquids (ILs) as 
adjuvants; and Na2SO4 and ILs.  
This work starts with an introduction to IgY and their physicochemical properties 
followed by the description of the methods commonly applied for the separation of 
antibodies from related contaminants.  
As a first approach several experimental studies were carried out using literature 
methodologies whereas the feedstock composition was followed/confirmed by sodium 
dodecyl sulfate polyacrylamide (SDS-PAGE) applied to egg yolk samples and pure IgY 
commercially acquired. After the proper evaluation of the feedstock, the studies on the 
selective partitioning and purification of IgY were initiated using ATPS. Several ATPS 
composed of polyethylene glycols (PEGs) of different molecular weight and Na2SO4 were 
initially investigated. After the selection of the most adequate polymer, one polymer-salt 
ATPS was used combined with different ILs and at different concentrations aiming at 
allowing the selective partitioning of IgY for a specific phase (whereas the impurities must 
be retained in the other phase). Finally, the ATPS composed of Na2SO4 and one of the 
improved ILs was also evaluated. To evaluate the potential systems capable of selectively 
extracting IgY from egg yolk, the total protein partition coefficients in each ATPS and the 
respective proteins profile were also determined. Novel phase diagrams composed of PEG 
+ Na2SO4 + water and PEG + Na2SO4 + IL + water were also determined to ascertain on 
the biphasic region and phases’ compositions.  
 
 
1.2. Antibodies 
Antibodies are proteins found in plasma and extracellular fluids of all vertebrate 
species and are members of a particular family of molecules, the immunoglobulins (Ig), 
which constitute the humoral branch of the immune system and form approximately 20 % 
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of the plasma proteins in humans [3, 19, 20]. Different populations of immunoglobulins are 
found on the surface of lymphocytes, in exocrine secretions and in extravascular fluids 
[19]. Antibodies are host proteins produced in response to bacteria, viruses, foreign 
molecules or other agents in the body [19, 20]. This response is a key mechanism used by a 
host organism to protect itself against the action of foreign molecules or organisms [19]. 
Each animal can produce millions of different antibodies, and each antibody is able to bind 
specifically to a particular foreign substance known as an antigen [3]. B-lymphocytes 
carrying specific receptors recognize and bind the antigenic determinants of the antigen 
and this motivates a process of division and differentiation, transforming the B-
lymphocytes into plasma cells. There are these lymphoid or plasma cells that 
predominantly synthesize antibodies [19].  
 
 
1.2.1. Antibody structure and function 
Antibodies are glycoproteins composed of four polypeptides. They contain a 
common structural domain found in many proteins and hence they are also referred to as 
immunoglobulins [3]. All antibodies have a common Y-shape based on the four 
polypeptide chain [20]. A pair of identical heavy chains, each of them carrying covalently 
attached oligosaccharide groups, is linked to another identical pair of non-glycosylated 
light chains by disulfide bonds resulting in a molecule of ~150 kDa [19, 20] (Figure 1).  
 
Figure 1 - Schematic representation of an antibody [20]. 
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In antibodies, the heavy chains are joined to each other by disulfide bonds located in 
a flexible region of the heavy chain known as the hinge, a region of approximately twelve 
amino acids that is exposed to enzymatic or chemical cleavage. Each globular region 
formed by the folding of the polypeptide chains as a result of the disulfide bonding is 
termed a domain. All polypeptide chains contain constant (C) and variable (V) regions, 
found at the carboxyl and the amino terminal portions, respectively [19]. Heavy and light 
chains have a single V region, while light chains possess a single C region. Heavy chains 
contain three C regions. The V regions of both heavy and light chains combine to form two 
identical antigen binding sites [19]. The heavy chains are responsible to give the 
characteristic of the immune system. Still, the light chains are the responsible to define the 
antigen-binding specificity [20]. The effect or functions of antibodies, such as placental 
transport or antigen-dependent cellular toxicity, are mediated by structural determinants 
within the fragment crystallizable (Fc) region of the immunoglobulin [19]. Depending on 
the Ig class that is determined by their heavy chain components, five structural molecules 
may be combined to form an antibody [3]. In mammals, there are five classes of Ig (IgG, 
IgM, IgA, IgD and IgE) whereas in hens there are three classes (IgY, IgM and IgA) [3]. Ig 
classes are distinguishable in the structure and in the temporal nature of the immune 
response [3, 21]. 
The interaction of an antigen is crucial to the antibody’s natural biological functions 
[3]. The specificity of the antibody response is mediated by T and/or B cells through 
membrane-associated receptors that bind a target antigen of a single specificity [3]. After 
binding to an appropriate antigen and receipt of various other activating signals, the B-
lymphocytes divide, which produce memory B cells as well as antibody secreting plasma 
cells clones [3, 19]. The memory of B-lymphocytes remains latent until they are 
subsequently activated by their specific antigen [3]. Lymphocytes provide the cellular basis 
memory and the resulting escalation in antibody response when re-exposed to a specific 
antigen [3]. Because most antigens are highly complex, they present numerous epitopes 
(antibody binding site) that are recognized by a large number of lymphocytes [3]. 
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1.2.2. Polyclonal and monoclonal antibodies 
Monoclonal and polyclonal antibodies are different in nature and the differences 
between those antibodies define the limitations of their use [20]. Polyclonal antibodies are 
most frequently produced in animals and recognize independent epitopes on the antigen 
and are able to bind to different substances [19, 20]. Each specific polyclonal antibody is 
produced by a clone of plasma cells because B-lymphocytes are activated to proliferate and 
differentiate into plasma cells [19, 20]. Serum is a very good source of polyclonal 
antibodies [19]. These antibodies are commonly used in immunochemical techniques to 
detect denatured proteins, using crude serum as the main source [19, 20]. In contrast, 
monoclonal antibodies are only produced by a single B-lymphocyte clone; therefore, all of 
them are identical [3, 20]. The high specificity of a monoclonal antibody, since it can only 
interact with a specific and unique substance, is a significant advantage, particularly in 
therapeutic applications [19, 20]. Monoclonal antibodies are frequently used in the form of 
tissue culture supernatants harvested from the hybridoma culture, or as crude extracts 
produced from hybridoma cells grown as tumors in syngenic mice. Production of 
monoclonal antibodies using hybridoma technology has been successful in the production 
of mouse monoclonal antibodies, but this has meant that therapeutic applications have 
always been associated with the risk of immunogenic reactions [19]. The main difference 
between them is that monoclonal antibodies are more specific than polyclonal antibodies. 
Due to their neat binding to the antigen, monoclonal antibodies are extremely efficient in 
the purification of mixtures of molecules. Unfortunately, their homogeneity also makes 
them less tolerant to denaturation (induced by pH or temperature variations) and 
degradation when compared to polyclonal antibodies. If denaturation occurs, the 
monoclonal antibodies become useless for applications, while the denatured polyclonal 
antibodies can still be used in some applications [20]. An example of this application is, for 
instance, immunoblotting from denaturing gels such as SDS-PAGE. 
 
 
1.3. Hen antibodies 
Hen egg is the largest biological cell known resulting from one cell division [21]. It 
is a storehouse of variable nutrients, namely proteins, lipids, carbohydrates and other 
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substances with biological functions that extend beyond basic nutrition [21, 22]. Hence, 
since the mid-1970s, many studies on the characterization on the biophysiological 
functions of egg components and the seeking of novel biologically active substances in hen 
eggs have been conducted [23]. Egg yolk, particularly, is considered as a major source of 
active principles because they also include a large quantity of antibodies which may be 
used in the medicinal, pharmaceutical, cosmetic and biotechnological areas [1, 22, 24]. In 
chicken there are three classes of antibodies: IgY, IgA and IgM [1]. IgA and IgM, similar 
to mammalian IgA and IgM, are secreted in the ripening egg follicle together with other 
proteins and are deposited into the egg white [1, 4, 21]. IgY is the functional equivalent of 
mammal IgG formed during egg formation. IgY in the serum is selectively transferred to 
the yolk via a receptor on the surface of the yolk membrane specific for IgY translocation 
and to passively protect the developing of chicks [1, 4]. In the egg yolk, IgY is the 
predominant and most important fraction of -livetin [22]. Livetins are a fraction of water-
soluble proteins that have three main components including α-, β-, and -livetin [22]. Egg 
white contains IgA and IgM at concentrations of around 0.15 a 0.7 mg·mL-1, respectively, 
whereas the yolk may contain from 5 to 25 mg·mL-1 of IgY [4, 24]. Mammalian 
equivalents of IgE and IgD have not been identified in chickens [4]. 
 
 
1.4. Molecular properties of IgY 
In 1969, Leslie and Clem reported the existence of an IgG-like molecule in chickens 
[4]. For many years, in older literature and even in commercial product catalogues, IgY is 
often mislabeled as IgG, due to its functional similarity to mammalian IgG. However, this 
older nomenclature is outdated, since the molecular properties of IgY and mammalian IgG 
are substantially different. 
 
 
1.4.1. Structure 
IgY contains two heavy and to light chains which are linked by a disulfide bridge, 
and has a molecular mass of ~180 kDa (larger than mammalian IgG (~159 kDa)) [1, 4, 25]. 
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IgY possesses a larger molecular weight heavy chain (68 kDa) as compared to that from 
mammals (50 kDa). The light chain of IgY consists of one variable (VL), and one constant 
domain (CL), like mammalian IgG [1, 25]. The intra-chain disulfide linkage between the 
VL region and the CL region of the light chain that exists in IgG is absent in the IgY light 
chain, and thus, intra-molecular forces of IgY are weaker than those of mammalian IgG 
[25]. The heavy chain of IgY has one variable domain (VH) and four constant domains 
(CH1; CH2; CH3 and CH4), in contrast to mammalian IgG which has three constant domains 
(CH1; CH2 and CH3) [1]. In the heavy chain of IgG, the CH1 and the CH2 domains are 
separated by a hinge region, which gives considerable flexibility to the Fab fragment (the 
portion which contains the antigen-binding activity) [25]. In contrast to IgG, IgY has a 
shorter and less flexible hinge region [1]. Comparisons of C-domain sequences in IgG and 
IgY have shown that the CH2 and CH3 domains of IgG are the equivalents of the CH3 and 
CH4 domains of IgY, respectively, and  the equivalent of CH2 domain of IgY is absent in 
the heavy chain of IgG [25]. In addition, the content of β-sheet structure in C domains of 
IgY is lower than that of mammalian IgG suggesting that the conformation of IgY domains 
is more disordered and less stable in comparison to mammalian IgG [1, 25]. As for IgG, 
the Fc part of IgY is the site with the most biological effector functions and contains two 
carbohydrate side-chains, in contrast to only one verified in IgG [25]. Figure 2 shows the 
differences between IgY and IgG. Both IgG and IgY are known to contain Asn-linked 
oligosaccharides. However, the structure of oligosaccharides in IgY differs from those of 
any mammalian IgG containing unusual monoglucosylated oligomannose type 
oligosaccharides with Glc1Man7-9GlcNAc2 structure [1, 4].  
 
 
 
Figure 2 - Structure of IgG and IgY [26]. 
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1.4.2. Physicochemical properties 
The isoelectric point of IgY is lower than that of IgG [25]. It is in the range of 5.7 to 
7.6, whereas that of IgG lies between 6.1 and 8.5 [1, 4, 25]. Since the Fc fragment (the 
most hydrophobic moiety of the antibody molecule) of the IgY is bigger than that of the 
IgG, the IgY molecule is more hydrophobic than the IgG molecule [25]. However, it has 
also been suggested that IgY can be more hydrophobic because of the lipid-rich fraction of 
egg yolk [1]. 
 
 
1.4.3. Stability 
The stability of IgY to acid and alkali media has been studied under various 
conditions. It was found that the activity of IgY was decreased at pH 3.5 or lower and 
almost completely lost with irreversible change at pH 3 [25, 26]. The rapid decrease of the 
IgY activity at low pH values indicated conformational changes. Nevertheless, the 
polypeptide is not broken down as observed by SDS-PAGE [25, 26]. Under alkaline 
conditions, the activity of IgY did not changed until a pH of 11 [25, 26]. However, it was 
markedly diminished at pH 12 or higher [1, 25]. Finally, the pH stability of IgY may be 
improved by the addition of stabilizers, such as sugars, complex carbohydrates or polyols 
[1].  
 
 
1.4.4. Proteolysis stability 
IgY is relatively resistant to trypsin or chymotrypsin digestion; yet, it is fairly 
sensitive to pepsin digestion [25]. Hatta et al. demonstrated that almost all of the IgY 
activity was lost by the digestion with pepsin, but 39 % and 41 % of the activity remained 
even after 8 h of incubation with trypsin or chymotrypsin, respectively [27]. The sensitivity 
of IgY to pepsin is highly dependent on the pH and on the enzyme/substrate ratio [1, 25]. 
At pH 5 or higher, IgY was fairly resistant to pepsin and retained its antigen-binding and 
cell-agglutinating activities [25]. However, at pH 4.5 or below, the antibody activity was 
completely lost at an enzyme to substrate ratio of 1:20 [1]. The results of Hatta et al., who 
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also observed the IgY behavior with pepsin under different incubation times and pH, 
confirmed the susceptibility of IgY to pepsin at low pH [27]. Digestion of IgY with pepsin 
at pH 2 resulted in the complete hydrolysis of the antibody molecule, leaving only small 
peptides when pepsin was used at an enzyme/substrate ratio of 1:200. Even though IgY 
was digested by pepsin at pH 4 it retained 91 % and 63 % of its activity after 1 h and 4 h of 
incubation time with the same enzyme/substrate ratio [27]. Following a tryptic digestion, 
IgY retained its antigen binding and cell-agglutinating activities in spite of a definite 
breakdown of the polypeptides. Unlike the trypsin digestion, no definite cleavage of the 
IgY chains was observed for chymotryptic digestion and the activities of IgY remained 
high for these digests [25].  
 
 
1.4.5. Temperature and pressure stability 
The binding activity of IgY with antigen decreases with increasing temperature and 
heating time [1, 25]. Minimal loss of activity was observed at temperatures ranging 
between 60 °C and 65 °C but it decreased markedly by heating for 15 min at 70 °C  
[1, 25, 26]. At temperatures higher than 75°C, IgY almost complete denatures [25]. 
However, addition of carbohydrates has been found to improve its resistance [1].  
IgY fractions have been stored in 0.9 % NaCl and 0.02 % NaN
3 
at 4 °C for over 10 
years without any significant loss of antibody titer [26]. The purified antibodies also 
retained their antigen binding capacity after 6 months at 20 °C or 1 month at 37 °C [26]. 
An egg yolk can be stored at 4 °C, with just a small loss of IgY activity, for at least six 
months [26]. 
IgY is relatively stable to pressure since no detectable inactivation of IgY was 
observed with pressures up to bar [25]. 
 
 
1.4.6. Freeze  and spray-drying stability 
Freezing and freeze-drying are processes that are usually considered to be less 
destructive and that do not affect the activity of IgY (unless repeated several times) [25]. 
However, Sunwoo et al. showed that frozen or freeze-dried IgY resulted in some loss of 
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antigen-binding activity and a substantial drop in the solubility under the conditions of high 
salt and protein concentrations [28]. Fu et al. studied the stability of IgY at various 
temperatures between 25 and 90 °C for a 15 min treatment, before and after a freeze-drying 
process [29]. The results provided by the authors reveal that freeze-dried IgY has a good 
thermal stability with no significant reduction in reactive activity, except at 90 °C [29]. 
This was also observed for the non-freeze-dried IgY [29]. Yokoyama et al. analyzed some 
properties of IgY powders obtained by spray or freeze-drying the water-soluble fraction of 
egg yolks from Escherichia coli immunized hens [30]. As compared to the freeze-dried 
powder, the spray-dried powder did not show a relevant alteration in antibody titres and 
yields, even with temperatures ranging between 140 to 170 °C [30]. Likewise, it has been 
shown that the addition of disaccharides or complex carbohydrates to IgY prior to freeze-
drying can improve the IgY stability during storage [1]. 
 
 
1.5. Extraction/ purification of IgY 
Although the chicken eggs are a convenient and economical source of antibodies, 
there are many difficulties on the extraction of IgY from egg yolk and, for this reason, the 
separation and purification of IgY from egg yolk has been considerably studied  
[4, 31]. Egg yolk is a fluid emulsion with a continuous phase of lipoprotein particles [4]. 
The major problem in isolating IgY from egg yolk relays on the separation of lipoproteins 
from egg yolk before the purification of IgY [4]. Based on this strategy, many purification 
methods of IgY have been reported, and are summarized and compared in Table 1. 
Many methods have been described using, for instance, simple water dilution, 
followed by centrifugation or ultrafiltration, to isolate the lipoproteins of the water-soluble 
proteins fraction (WSPF) [31-33]. This method is based on the aggregation of yolk 
lipoproteins at low ionic strengths [4]. For these dilution methods, optimization of the 
operational conditions (pH, temperature, dilution factor, etc.) has allowed the increase on 
the IgY recovery up to 90 % [32]. However, different authors have accomplished different 
results and have thus different perspectives. Nakai et al. reported that the best results were 
obtained using a six-fold water dilution, at pH 5.0 [34]. Yao Luo et al. showed that the 
enhanced results were obtained with a fifteen-fold water dilution [35]. Marcet et al. advised 
that the egg yolk should suffer a 1.5 water dilution, at pH 7 [22].  
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According to literature the main components of WSPF are IgY, α-livetin, β-livetin, 
low density lipoproteins and albumin [33]. Therefore, IgY must be purified from WSPF 
after a first step involving the lipoproteins precipitation [4, 33]. The recovery of IgY has 
been carried out with the addition of ammonium sulfate [34-36], sodium sulfate [31, 34], 
sodium alginate [23], cadmium sulfate [37], zinc sulfate [37] and dextran sulfate [34]. 
Beyond the water dilution methods, other approaches were developed to separate IgY 
from the lipoproteins and other impurities including deslipidation by organic solvents 
(isopropanol [38] and chloroform [39]) and by a mixture with κ-carrageenan, low-
methoxyl pectin and CaCl2 [40], and lipoprotein precipitation using PEG [22, 34, 39, 41], 
dextran blue [42], natural gums (such as xanthan gum) [34] or caprylic acid [38]. 
Ion exchange chromatography has also been used as a final step in the IgY 
purification, as well as hydrophobic interaction chromatography [4]. Because of the failure 
of IgY to bind to proteins A and G, and its sensitivity to traditional affinity purification 
conditions, several other methods of affinity chromatography have been examined for the 
purification of IgY, including immobilized metal ion affinity chromatography, thiophilic 
interaction chromatography, affinity chromatography using alkaline conditions and 
synthetic peptide ligands specifically designed for immobilizing antibodies [4, 39].  
The use of supercritical fluids has also been employed as a separation method. 
Nevertheless, high costs have deemed this process as non-viable [43]. 
Stimulated by an increasing demand for IgY-based technologies, several commercial 
suppliers have developed IgY purification kits. Two of the most prominent (Thermo 
Pierce's Eggcellent™ and Promega'sEGGstract®) are based on a delipidation step followed 
by the IgY precipitation/purification [40]. Although both kits are particularly user friendly 
and do not involve the use of organic solvents they are particularly expensive given the 
yield of IgY produced (up to $67 USD per egg). Furthermore, none of these commercially 
available options is available in a scalable commercial level [40]. 
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Table 1 - Comparison of the literature methods for purifying IgY. 
*Purification (fold) - The final volume of the sample divided by the initial volume of the egg yolk used.  
**The IgY content in the purified sample divided by the original IgY content in the egg yolk. 
(----)– Non-determined. 
 
Purification method 
IgY 
recovery 
(%) 
Total 
protein 
(mg) 
IgY 
(mg·ml-1) 
Purity 
of IgY 
(%) 
Reference 
Water dilution 91 773 (----) 31 [34] 
(----) (----) (----) 85 [44] 
Ultrafiltration 87 (----) (----) > 93 [31] 
(----) (----) 9.8 94 [34] 
91 (----) (----) 85 [32] 
P
re
ci
p
it
at
io
n
 a
n
d
 e
x
tr
ac
ti
o
n
 
Polyethylene glycol (PEG) 64.0 348 (----) 15.8 [39] 
(----) (----) 4.9 89 [45] 
47 501.6 (----) 25 [34] 
Dextran sulfate 71 (----) (----) (----) [34] 
(----) (----) 7.5 87 [46] 
Sodium sulfate (----) (----) 9.8 94 [34] 
Ammonium sulfate (----) 6.1 3.8 62.1 [37] 
(----) (----) 60 ~80 [40] 
Cadmium sulfate (----) 6.2 1.9 31.8 [37] 
Dextran blue 79.2 ND (----) 16.7 [39] 
Caprylic acid 97/90**  160/120 4.0/4.3
* 
[38] 
Zinc sulfate (----) 5.8 2.4 41.2 [37] 
Isopropanol 69/58**  160/120 1.0/1.1
* 
[38] 
Chloroform 65.1 275 (----) 14.0 [39] 
N
at
u
ra
l 
g
u
m
s Xanthan gum 
72 601.0 (----) 32 [34] 
(----) (----) 7.3 89 [47] 
C
h
ro
m
at
o
g
ra
p
h
y
 Ion exchange chromatography 
(----) (----) (----) (----) (----) 
Affinity chromatography 
(----) (----) 65 > 90 [39] 
Hydrophobic interaction 
chromatography 
(----) (----) (----) (----) (----) 
 Commercial kit (----) (----) (----) 70-90 [40] 
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All methods described before have in common the recovery and purification of IgY 
from the native egg yolk. Hence, IgY is the only compound recovered and many egg yolk 
compounds are lost [8]. Although several methods for the purification of IgY have been 
described in literature, all are time-consuming, labor intensive, low yielding, high cost and 
cannot easily be scaled-up for industrial applications [31, 39, 40].  In addition, in some of 
these protocols the solvents used are not innocuous and can lead to the appearance of 
solvent residuals in the final products and alter the IgY functionality. 
In most of the studies reported in literature, SDS-PAGE was carried out as the main 
chromatographic technique to confirm the presence of IgY at the different steps of the 
isolation process [5, 22, 23, 31, 32, 40, 44]. 
 
 
1.6. Application of IgY 
The polyclonal antibodies produced by chickens can be shaped against a large 
number of antigens [48]. They can be applied in many different methods for various 
purposes as academic research, diagnostic, therapeutic reagents, as a tool for purification or 
detection of antigens and as a protective agent in passive immunization. IgY are excellent 
alternatives for their mammalian counterparts in what concerns the passive immunization 
ability [48, 49]. In Table 2 some of the antigens produced and their applications are 
presented. IgY demonstrated to act in almost all the tested immunological methods that 
were traditionally developed for mammalian IgG (immunofluorescence, immnoenzyme 
techniques, immunoelectrophoresis and Western blotting, immunohistochemistry and 
many others) [48].  
IgY is successfully used in immunochemistry to detect antigens of viral bacteria, 
plants and animal origins, and the contamination of foods with toxins and drugs [6].  
Due to its distinctness from IgG, IgY has also been found to be advantageous in 
several immunodiagnostic techniques, as well as in immunoaffinity purification, in many 
cases replacing IgG, which is reflected in a great reduction of background and false results 
[4, 48].  
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Table 2 - Antigens used to produce specific polyclonal IgY and their applications [48]. 
Antigen Application 
Human IL-6 RE 
Human manose 6-phosphate/insulin-like growth factor-II receptor RE 
Humantransferin RE 
α-subunit of hypoxia-inducible factor 1 (HIF-1) RE 
Helyobacterpylori RE, TE 
Choleratoxin B RE 
Rabies virus RE 
Sendaivirus RE 
Rabbitmuscleactin RE 
Humanrotavirus RE, DE 
Bovine growth hormone and prolactin RE, DE 
Lactoferin RE, DE 
Activin A RE, DE 
Mucin-likeglycoprotein A DE 
α-subunit of insulin receptor DE 
Toxoplasmagondii DE 
Rat liver cytosolic casein kinase II DE 
Chlamidiae DI 
Campylobacterfetus DI 
Cartilage gp-39 DI 
Hepatitis B surfaceantigen DI 
Humanbloodantigens DI, RE 
Influenza virus DI, RE 
AsialoGM1 (T-antigen in human colorectal adenocarcinom) DI, RE 
Calf thymus RNA polymerase II DI, RE, TE 
Plasmid (naked) DNA DI, TE 
E7 oncogenic protein of human papillomavirus type 16 DI, TE 
P110 protein (antigen of human stomach cancer) DI, TE 
Ig and blood components of several mammalian species DI, PU 
Human -2 plasmin (its carboxy-terminal peptide) PU 
Porcineendothelialcells TE 
E. coli PI 
Animal venoms (snake, viper, rattlesnake, scorpion) PI 
Streptococcus mutansglucan binding protein B PI 
RE, research reagent; PU, purification of antigens; DE, detection of antigens; DI, diagnostic reagent; TE, 
therapeutic reagent; PI, used in passive immunization 
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During the past decade, IgY was reported to be used as immunotherapeutic agents 
against pathogens that are difficult to treat with traditional antibiotics [48]. Shin et al. were 
able to identify the immunodominant proteins of H. pylori [50]. IgY antibodies with 
specificity against these proteins were effective and demonstrated a curative effect of the 
anti-H. pylori antibodies. In most cases no complete H. pylori eradication could be 
achieved, but in view of the increasing bacterial resistance, the use of specific IgY 
antibodies can minimizes the use of antibiotics [50]. The use of IgY for passive and 
protective immunization against gastrointestinal pathogens in humans and animals have 
also been studied extensively [1, 48]. 
Passive immunity refers to the process of providing preformed antibodies to protect 
against infection, and it provides immediate but short-lived protection lasting several 
weeks to three or four months at most. Passive immunity can be classified as natural, when 
maternal antibodies are transferred to the offspring or acquired, when high levels of 
antibodies specific for a pathogen or a toxin are recovered from immunized individuals or 
from patient recovering from the infection and administered to non-immune individuals [1, 
25]. The transfer of antibodies may be carried out via systemic, intravenous or oral routes 
[25]. IgY has been found to be effective against a number of human pathogens and 
diseases, both in vitro and in laboratory animal studies and clinical settings [25]. Casswall, 
Carlander et al., and Sarker et al. investigated the action of hyperimmune bovine colostrum 
(HBC) and the oral administration of IgY antibodies with significant protective effect [51-
53]. Worledge et al. demonstrated significant protective effects after oral application of 
specific IgY against tumor necrosis factor (TNF) in an experimental rat model for colitis 
[54]. TNF is implicated in the pathogenesis of inflammatory bowel disease [49]. Carlander 
et al. studied the benefits of IgY as a prophylactic tool against infectious diseases in 
patients with cystic fibrosis (CF), the most common fatal genetic disease of the Caucasian 
population in Europe and in the USA [55]. These oral IgY treatments were successful in 
reducing chronic P. aeruginosa infections in CF patients, and thus resulted in a decrease in 
antibiotic prescriptions [49]. 
A new and an interesting field of the use of the IgY-technology is the proteomic 
analysis. A major problem in the separation of complex protein mixtures by  
2D-electrophoresis is the predominance of high-abundant proteins like albumin which 
disturb the monitoring of low-abundant proteins. Low-abundant proteins can be of high 
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importance for identification and monitoring several human (and animal) diseases. 
Recently, it has been shown that IgY antibodies directed against these high-abundant 
proteins are in fact useful tools for their removal. In addition, these antibodies work more 
specific than matrices with affinity to albumin like for example blue sepharose [49]. 
 
 
 
 
 
1.7. Production of IgY 
The production of large amounts of IgY in a cost-effective manner is the key for a 
successful passive immunization. The development and production of specific IgY can be 
achieved by immunizing laying-hens with the target antigen [25]. The immune response of 
immunized hens cannot be very predictable due to five factors that influence the immune 
response and which are: the antigen dose and molecular weight, the type of adjuvant used 
the route of application, the immunization frequency, and the interval between 
immunizations [25].  
 
 
1.7.1. Antigen 
The dose of antigen influences the immune response and the antibody titre [25]. Too 
much or too little antigen dosages may induce suppression, sensitization, tolerance or other 
unwanted immunomodulation [25]. Behn et al. achieved better results when injecting hens 
with 0.1 mg of mouse IgG, instead of 1.0 mg. Schwarzkopf et al. found that the injection of 
Figure 3 - Passive immunization process [1]. 
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antigen concentrations ranging between 10 µg and 1 mg elicited good antibodies responses 
[56]. Therefore, for each antigen, various concentrations have to be tested since the type of 
antigen should be also considered [25]. Antigens can be present in the immune system as 
complex multiantigens (e.g., bacteria) or as single antigens (e.g., proteins). Proteins are 
recognized to be the most efficient immunogens because of the polymorphism of their 
structure and the differences existing between species and individuals. As a general rule, 
only 10-100 µg of protein antigen is enough [25]. Peptides (with a molecular weight below 
10 kDa) can also be used as antigens, but they should be coupled to carriers (e.g., bovine 
serum albumin). Polysaccharides antigens are efficient too. However, lipid and nucleic 
acids are not potent immunogens unless they are coupled to proteins or polysaccharides 
[25]. 
 
 
1.7.2. Adjuvant 
The induction of high egg yolk antibody titres can be also achieved by the use of 
adjuvants [25]. There are more than 100 known adjuvants, which differ in their chemical 
characteristics, their efficacy in stimulating the immune system, and their secondary side-
effects [25]. Oil-based adjuvants, such as Freund’s complete adjuvant (FCA), remain the 
most effective for antibodies production in laboratory animals  
[1, 25]. However, FCA has been associated with potentially severe injection site reactions 
[1]. To avoid an eventual local tissue reaction, the Freund’s incomplete adjuvant (FIA), 
which is the most effective substitute found to date, becomes now the most commonly used 
adjuvant to produce egg yolk antibody. Since FIA is less efficient than FCA, some 
investigators preferred the use of a combination of the two adjuvants: FCA for the first 
immunization and FIA for the following immunizations [25]. 
 The use of DNA vaccines has also been reported for IgY production. In this process 
the animals are immunized with plasmid DNA encoding the antigen of interest and 
eliminating the potentially tedious and costly process of purifying antigens [1].  
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1.7.3. Route of application 
The most common injection route in hens for IgY production is the intramuscular 
route. Intramuscular immunization results in higher levels of specific IgY when compared 
to antigen injected subcutaneously [1]. Injection is usually performed in the breast muscle 
[25]. Chicken can also be injected subcutaneously in the neck. With very young animals, it 
may be preferable to inject intramuscularly into the breast muscle, because subcutaneous 
injection is more difficult to perform and can therefore cause more distress [25].  
 
 
1.7.4. Immunization frequency an interval between immunizations 
The total number of immunizations necessary for the production of IgY depends on 
the type and dosage of the antigen as well as the adjuvant employed. At least two 
immunizations have to be given. Yolk antibody titres should be checked fourteen days 
after the last immunization. If antibodies titres begin to decrease, following immunizations 
can be given during the laying period to maintain production of high levels of specific 
antibodies up to one year [25]. The success of an immunization protocol depends also on 
the interval between the first and second and subsequent immunizations. This interval is 
between two to four weeks [25].  
 
 
1.8. Advantages of IgY 
Polyclonal antibodies have been conventionally isolated from sera of animals such as 
rabbits, goats and sheep superimmunized with an aimed antigen [2]. However, the use of 
chickens for the production of polyclonal antibodies provides several advantages [4, 19].  
IgY is produced by a non-invasive method which does not cause pain to animals or 
lead to their dead since it is based on a simple act of collecting eggs, and so, the production 
of IgY from eggs is easier than that of IgG from serum [21, 22]. The preparations methods 
of IgG and IgY are shown in Figure 4. Moreover, few eggs per week can provide the same 
amount of immunoglobulin as repeated bleeding of an immunized mammalian. Usually 
more than 100 mg of IgY can be isolated per egg [19, 21]. Several works published 
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comparative studies on the production of antibodies by immunized hens and rabbits sera 
[21, 46, 57]. Jensenius et al. estimated that the total antibody activity of the eggs laid by a 
hen in a month is equivalent to that produced in a half liter of serum from an immunized 
rabbit [46]. Gottstein and Hemmler reported that the quantity of IgY obtained from eggs 
laid by an immunized hen was 18 times higher than that of IgY isolated from the serum of 
an immunized rabbit [57]. Mujo Kim et al. also compared the productivity of IgY from 
eggs laid by a hen over a year with that of IgG from the entire serum of a rabbit in which 
both animals were immunized with the same antigens and the productivity of IgY exceeded 
the productivity of IgG [21].  
 
 
 
 
Furthermore, an industrial scale production of IgY is plausible because of the 
availability of a large number of chicken farms and automation of egg breaking and 
processing [21]. Therefore, chicken eggs are considered as a potential source of large-scale 
production of IgY [22]. 
On the other hand, compared to its mammalian IgG counterpart, IgY neither binds to 
the mammalian or bacterial Fc receptor, it does not activate the complement system or 
interact with the rheumatoid factor [40]. Not surprisingly, IgY antibodies also show far 
superior immunogenicity against highly conserved mammalian proteins making the 
Figure 4 - Preparation of specific antibodies [21]. 
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production of IgY orders of magnitude more efficient than current IgG production using 
rabbits, donkeys and mice [40].  
Table 3 shows the advantages associated with the production of antibodies in chicken 
and compares the characteristics of mammalian IgG and avian IgY. 
 
Table 3 - Comparison between the mammalian IgG and avian IgY [4, 58]. 
 Mammalian IgG Avian IgY 
Source of antibody Blood serum Egg yolk 
Kind of antibody Polyclonal Polyclonal 
Antibody sampling Invasive - bleeding Non-invasive – collecting eggs 
Antibody yield 
200 mg/ bleed 
(400 mL blood) 
100-150 mg/ egg 
(5-7 eggs per week) 
Antibody yield per month 200 mg ~ 1500 mg 
Specific antibody yield ~ 5 % 2-10 % 
Protein A/G binding Yes No 
Interaction with rheumatoid 
factor 
Yes No 
Activation of mammalian 
complement 
Yes No 
 
 
1.9. Extraction of IgY using ATPS 
1.9.1. Extraction of biomolecules using ATPS 
There are two main processes commonly used to extract biomolecules from a liquid 
phase to another: liquid-liquid extraction using water immiscible organic solvents and 
aqueous two-phase systems (ATPS). This last extraction method uses two incompatible 
solutes dissolved in aqueous media and are known since 1896 when Beijerinck discovered 
agar and gelatin form two macroscopic liquid aqueous phases  
[2, 6, 59]. Nevertheless, ATPS as extractive/separation techniques were only introduced by 
Albertson in 1955 [2, 8, 60]. Albertson demonstrated that a concentrated solution of an 
organic polymer, such as PEG, and an inorganic salt, such as dibasic sodium or potassium 
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phosphate (K2HPO4), formed two liquid phases: the upper phase contains most of the PEG 
and the lower phase contains most of the inorganic salt [60]. ATPS are thus formed when 
two mutually incompatible hydrophilic solutes are dissolved in water above certain 
concentrations [6, 8]. These solutes can either be two polymers, a polymer and a salt, or 
two salts [2, 6].  
ATPS are a powerful, non-chromatographic process for the separation and/or 
purification of biomolecules, and which have been successfully applied in the purification 
of different biological materials, such as cells, viruses, organelles, nucleic acids, lipids, 
amino acids, proteins, antibodies and enzymes without significant denaturing effects [6, 8, 
60]. Moreover, this technique is relatively simple and inexpensive, is easily operated and 
scaled-up, has a high resolution capacity, and allows the purification and concentration to 
be integrated in a single step procedure [6, 8].  
The partition of a target product in ATPS depends on a number of parameters related 
to the system properties [2, 5]. The extrinsic properties concern the type, molecular weight 
and concentration of phase forming components, ionic strength, pH, temperature and 
others [5]. The intrinsic properties include size, electrochemical properties, surface 
hydrophobicity and hydrophilicity and conformal characteristics of both the phases and of 
the solute to be extracted [5]. The complexity of the chemical and physical interactions 
involved in the partitioning process can make these systems very powerful in contrast to 
other established separations techniques [2]. 
Conventional ATPS are typically formed by polymer-polymer or by polymer-
inorganic salt mixtures. These ATPS are usually chosen for the extraction/purification of 
biomolecules, such as proteins, due to their biocompatibility since both phases consist 
mainly of water (80-90 wt %) and most of the polymers have a stabilizing effect on the 
protein tertiary structure [5, 6, 8].  
PEG is common used as one of the phase forming polymers in ATPS because it 
presents a high biodegradability, low toxicity, low volatility, low melting temperature, 
large water miscibility and low cost [12, 59]. PEG is as polyether diol that is commercially 
available in a variety of molecular weights [5]. Salt-polymer-type ATPS provide 
advantages over ATPS formed by polymer-polymer combinations, such as a low interfacial 
tension, fast and high phase separation rates and low cost, which makes them more viable 
for downstream processing [12]. Despite all these advantages, the hydrophilic nature of 
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PEG limits the applicability of this technique when the goal is to extract hydrophobic 
biomolecules [12]. To overcome this limitation, recent works have introduced ionic liquids 
(ILs) to tune the properties of PEG through the modification of its chemical structure and 
thus increase the extraction yield [61, 62]. Moreover, an additional work proved that the 
addition of small quantities of ILs to conventional polymer-salt-ATPS leads to different 
partitioning behaviors that are dependent on the IL employed as adjuvant (at 5 wt %) [12]. 
Therefore, the use of ILs in conventional systems seems to provide tailored and optimized 
extractions by a proper choice of the IL used as phase-forming component. 
ILs are salts that are liquid below a conventional temperature of 100 ºC and they are 
usually composed of a large asymmetric organic cation and either an organic or inorganic 
anion. The most studied ILs are the nitrogen-based and their general cation structures are 
present Figure 5.  
 
 
Figure 5 - Cation structures of nitrogen-based ILs. 
 
Due to their ionic character, these fluids present outstanding properties such as a 
negligible vapor pressure, null flammability, high ionic conductivity, as well as high 
thermal and electrochemical stabilities. Besides the ILs negligible volatility and  
non-flammability, which have contributed to their being labeled as “green solvents”, one of 
the main advantages of the use of ILs in ATPS is the possibility of tailoring their phases’ 
polarities and affinities by an adequate manipulation of the cation/anion combinations - 
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“designer solvents”. Unlike most traditional molecular solvents, ILs can be regarded as 
nano-segregated media, composed of a polar network permeated by  
non-polar domains [63]. These domains allow the ILs to interact selectively with different 
types of solute/solvent and improved properties and applications can always be foreseen. In 
this context, ILs cover a much wider hydrophilic-lipophilic range allowing for more 
extensive and selective separations. In fact, ATPS with ILs have been intensively 
investigated for the extraction of the most diverse (bio)molecules  
[10, 12, 13, 15] where results up to complete extraction were achieved.  
 
 
1.9.1.1. Phase diagrams and  respective properties 
ATPS have a unique phase diagram under a particular set of conditions such as pH 
and temperature [59]. Phase diagrams provide information about the concentration of the 
phase forming components required to form a two-phase system, the concentration of the 
phase components in the top and bottom phases, and the ratio of phase volume or weight 
[59]. The binodal curve of a phase diagram divides two regions: the monophasic region 
(bellow the curve), where at these concentrations the system is monophasic, and the 
biphasic region (above the curve), where the concentration of the components will form 
two immiscible aqueous phases. The binodal data are thus initially required for the design 
of proper ATPS extraction processes and to the development of models to predict the 
partitioning of biomolecules [59]. Figure 6 shows an example of a binodal curve, TCB, and 
three mixture compositions at the biphasic region, X, Y and Z. All systems have a different 
initial composition and different volume ratios. The example provided by the mixtures X, 
Y and Z are along the same tie-line (TL) meaning that all the initial mixtures will present 
the same top phase equilibrium composition (TPEG, TSalt) and the same bottom phase 
composition (BPEG, BSalt) [59].  
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Figure 6 - Binodal curve: TCB = binodal curve; C = critical point; TB = tie-line; T = composition of the top 
phase; B = composition of the bottom phase; X, Y and Z = mixture compositions at the biphasic region [59]. 
 
The units of tie-line length (TLL) are given in the same units used for representing 
the components concentration [59]. The length of each tie-line is related to the weight of 
the phases and defines the difference in compositions among the coexisting phases [59].  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Experimental section 
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2.1. PEG + Na2SO4 + H2O ternary systems 
2.1.1. Chemicals 
The ATPS studied in this work were established by using an aqueous solution of 
sodium sulfate anhydrous, Na2SO4 (100 % pure from Prolabo), and different aqueous 
solutions of PEGs. The PEGs studied were of molecular weight 200 g·mol
-1
,  
300 g·mol
-1
, 400 g·mol
-1
 and 600 g·mol
-1
 and abbreviated as PEG 200, PEG 300,  
PEG 400, and PEG 600. All the PEGs were from Fluka with the exception of PEG 300 that 
was from Sigma-Aldrich. 
The water employed was double distilled, passed across a reverse osmosis system 
and further treated with a Milli-Q plus 185 water purification apparatus.  
A saline buffered aqueous solution using commercial Phosphate Buffer Saline tablets 
(PBS), from Sigma-Aldrich, was also prepared and used as the aqueous phase to maintain 
the pH of the ATPS at 7.4. 
 
 
2.1.2. Experimental procedure 
2.1.2.1. Phase diagrams 
The binodal curve of each phase diagram was determined through the cloud point 
titration method at 298 K (± 1 K) and atmospheric pressure [6]. This procedure was 
initially validated with the phase diagram of PEG 600 + Na2SO4 + water already reported 
in literature [12] (cf. Appendix A - Figure A 1). Aqueous solutions of Na2SO4 at 17 wt % 
and aqueous solutions of the different PEGs at 70 wt % were prepared and used for the 
phase diagrams determination. Repetitive drop-wise addition of the aqueous inorganic salt 
solution to each PEG solution was carried out until the detection of a cloudy biphasic 
solution, followed by the drop-wise addition of water until the detection of a monophasic 
region (clear and limpid solution). Drop wise additions were carried out under constant 
stirring. The ternary systems compositions were determined by the weight quantification of 
all components added within an uncertainty of ± 10
-4
 g.   
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2.1.2.2. Determination of TLs 
The tie-lines (TLs) were determined by a gravimetric method originally described by 
Merchuck et al. [64]. A mixture at the biphasic region was gravimetrically prepared with 
PEG + salt + water, vigorously stirred, and allowed to reach the equilibrium by the 
separation of both phases for at least 12 h at 298 K (± 1 K). After the separation step, both 
top and bottom phases were weighted. Finally, each individual TL was determined by the 
application of the lever-arm rule to the relationship between the top phase weight and the 
overall system composition. The experimental binodal curves were fitted using Equation 1 
[64]: 
 
                                        (1) 
 
where       and        are, respectively, the PEG and salt weight percentages and  ,   
and   are constants obtained by the regression. 
For the determination of TLs it was solved the following system of four equations 
(Equations 2 to 5) and four unknown values (        ,          ,           and           ): 
 
                         
                
       (2) 
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The subscripts    ,      and   represent the top, bottom and the mixture phases, 
respectively. The parameter α is the ratio between the top weight and the total weight of the 
mixture. The solution of the referred system gives the concentration of the IL and salt in 
the top and bottom phases. For the calculation of the tie-line lengths (TLLs) it was applied 
Equation 6. 
 
(4)
(5) 
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                                                               (6) 
 
 
2.2. PEG + Na2SO4 + H2O + IL quaternary systems 
2.2.1. Chemicals 
The ATPS studied in this work were established by using aqueous solutions of 
sodium sulfate anhydrous, Na2SO4 (100 % pure from Prolabo), PEG, from Sigma Aldrich, 
and several ILs of different chemical structures. The ILs studied were:  
1-butyl-3-methylimidazolium thiocyanate, [C4mim][SCN] (> 98 wt % pure);  
1-butyl-3-methylimidazolium tosylate, [C4mim][TOS] (98 wt % pure);  
1-butyl-3-methylimidazolium dicyanamide, [C4mim][N(CN)2] (> 98 wt % pure);  
1-butyl-3-methylpyridinium dicyanamide [C4mpy][N(CN)2] (> 98 wt % pure);  
1-ethyl-3-methylimidazolium dicyanamide, [C2mim][N(CN)2] (98 wt % pure) and  
1-butyl-3-methylimidazolium acetate, [C4mim][CH3CO2] (98 wt % pure). All the ILs were 
supplied by Iolitec and their chemical structures are shown in Figure 7.  
To reduce the water and volatile compounds content to negligible values, ILs 
individual samples were dried under constant agitation at vacuum and moderate 
temperature (≈ 323 K) for a minimum of 24 h. After this process, the purity of each IL was 
further checked by 
1
H and 
13
C NMR spectra and found to be in accordance with the purity 
given by the suppliers.  
The water employed was double distilled, passed across a reverse osmosis system 
and further treated with a Milli-Q plus 185 water purification apparatus.  
A saline buffered aqueous solution using the commercial Phosphate Buffer Saline 
tablets (PBS), from Sigma-Aldrich, was also prepared and used to prepare the phase 
diagrams and liquid-liquid extractive systems. 
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2.2.2. Experimental procedure 
2.2.2.1. Phase diagrams 
The binodal curves of the quaternary phase diagrams were determined through the 
cloud point titration method at 298 K (± 1 K) and atmospheric pressure [6]. This procedure 
was initially validated with the phase diagram obtained for PEG 600 + Na2SO4 + 
[C4mim]Cl + water quaternary system against literature data [12] (cf. Appendix A- Figure 
A 2). Aqueous solutions of Na2SO4 at 17 wt % and aqueous solutions of PEG 300 at 70 wt 
% were prepared and used for the phase diagrams determination. All the aqueous solutions 
used in the determination of the phase diagrams contained the same concentration of IL  
(5 and 10 wt %). Repetitive drop-wise addition of the aqueous IL-inorganic salt solution to 
Figure 7 - Chemical structures of the studied ILs: (i) [C4mim][SCN]; (ii) [C4mim][TOS];  
(iii) [C4mim][N(CN)2]; (iv) [C4mim][CH3CO2]; (v) [C4mpy][N(CN)2]; (vi) [C2mim][N(CN)2]. 
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the IL-PEG solution was carried out until the detection of a cloudy and further biphasic 
solution, followed by the drop-wise addition of the IL-water mixture until the detection of 
a monophasic region. All this procedure was carried out under constant stirring. The 
quaternary systems compositions were determined by the weight quantification of all 
components added within an uncertainty of ± 10
-4
 g.   
 
 
2.2.2.2. Determination of TLs 
The tie-lines (TLs) were determined by a gravimetric method originally described by 
Merchuck et al. [64]. A mixture at the biphasic region was gravimetrically prepared with 
PEG + salt + water + IL, vigorously stirred, and allowed to reach the equilibrium by the 
separation of both phases for at least 12 h at 298 K (± 1 K). After the separation of the 
coexisting phases they were further weighted. Finally, each individual TL was determined 
by the application of the lever-arm rule to the relationship between the top phase weight 
and the overall system composition. The fitting of the experimental binodal curves, the 
determination of TLs and TLLs was determined according to Equations 1 to 6 described 
before. 
 
 
2.3. Purification of IgY using ATPS 
2.3.1. Chemicals 
Fresh eggs were purchased in supermarkets of the Aveiro region. The aqueous 
solutions of egg yolk were prepared in saline buffered solutions using the commercial 
Phosphate Buffer Saline tablets (PBS) from Sigma-Aldrich to maintain the pH of the 
systems circa to 7.4. Sodium sulfate (Na2SO4), 100 % pure from Prolabo, PEGs of 
different molecular weight and several ILs were used for the formation of ATPS to be used 
as purification systems. The PEGs studied were: PEG 200, PEG 300, PEG 400, and PEG 
600. All the polymers were acquired from Fluka with the exception of PEG 300 that was 
from Sigma-Aldrich. The ILs used were: 1-butyl-3-methylimidazolium thiocyanate, 
[C4mim][SCN] (> 98 wt %); 1-butyl-3-methylimidazolium tosylate, [C4mim][TOS] (98 wt 
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%);1-butyl-3-methylimidazolium acetate, [C4mim][CH3CO2] (98 wt % pure); 
1-butyl-3-methylimidazolium dicyanamide, [C4mim][N(CN)2] (> 98 wt % pure);  
1-ethyl-3-methylimidazolium dicyanamide, [C2mim][N(CN)2] (98 wt % pure); 
trihexyltetradecylphosphonium dicyanamide, [THTDP][N(CN)2] (95.7 wt % pure);  
1-butyl-3-methylpyridinium dicyanamide, [C4mpy][N(CN)2] (> 98 wt % pure);  
1-butyl-3-methylimidazolium tricyanomethane, [C4mim][C(CN)3] (98 wt % pure);  
1-hexyl-3-methylimidazolium dicyanamide, [C6mim][N(CN)2] ( 99 wt % pure). The ILs 
molecular structures are shown in Figure 8. All the ILs were supplied by Iolitec with the 
exception of [THTDP][N(CN)2] that was kindly supplied by Cytec Industries Inc. and 
[C4mim][C(CN)3] that was from Merck. To reduce the water and volatile compounds 
content to negligible values, the ILs were dried at vacuum and moderate temperature  
(≈ 350 K) for a minimum of 24 h under constant agitation. After this process, the purity of 
each IL was checked by 
1
H and 
13
C NMR spectra and found to be in accordance with the 
purity given by the suppliers.  
The water employed was double distilled, passed through a reverse osmosis system 
and treated with a Milli-Q plus 185 water purification apparatus.  
The material necessary to the SDS-PAGE analysis include: 
tris(hydroxymethyl)aminomethane, PA from Pronalab; sodium dodecyl sulfate, SDS  
(> 98.5 wt % pure), from Sigma-Aldrich; glycerol, 99.5 wt % pure, from Sigma-Aldrich; 
bromophenol blue and acid acetic, 99.8 wt % pure, from Merck; dithiothreitol, DTT  
(99 wt % pure), from Acros; and methanol, HPLC grade, from Fisher Scientific. The 
Amersham ECLGel Box, the Amersham ECL Running Buffer (10X), the Amersham ECL 
Gel 4-20 %, 10 wells, and the Full-Range Rainbow Molecular Weight Marker were 
acquired from GE Healthcare. The Coomassie Brilliant Blue G-250 was purchased from 
Sigma Aldrich. 
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Figure 8 – Chemical structure of the ILs studied: (i) [C4mim][SCN]; (ii) [C4mim][TOS]; (iii) 
[C4mim][N(CN)2]; (iv) [C4mim][CH3CO2]; (v) [C2mim][N(CN)2]; (vi) [C4mim][C(CN)3]; (vii) 
[C4mpy][N(CN)2]; (viii) [THTDP][N(CN)2]; [C6mim][N(CN)2]. 
 
 
2.3.2. Experimental procedure 
2.3.2.1. ATPS composed of PEG + Na2SO4  
To obtain the initial aqueous solution of egg yolk from fresh eggs to be applied in the 
subsequent purification step the procedure described by Liu et al. was here used [31]. The 
water-phase was then recovered and used in the formation of each ATPS. The ternary 
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(7) 
mixtures compositions were chosen based on the phase diagrams determined before for 
each PEG-Na2SO4 ATPS (without IL).  
 Each mixture was prepared gravimetrically within  10-4 g and vigorously stirred 
and left to equilibrate for at least 12 h (a time period established in previous optimizing 
experiments) and at 298 K, to achieve the complete partitioning of IgY and other 
contaminant proteins between the two phases.  
In all the ternary mixtures evaluated, and at the compositions used, the PEG-rich 
aqueous phase is the top layer while the salt-rich aqueous phase corresponds to the bottom 
layer.  
After the separation of the phases, using small ampoules designed for the purpose, 
the amount of total protein was quantified in each phase and the partition coefficients and 
the respective standard deviations were further determined. The total proteins content was 
quantified through UV-spectroscopy, using a SHIMADZU UV-1700, Pharma-Spec 
Spectrometer, at a wavelength of 280 nm. A previous calibration curve was established 
using BSA (cf. Annex B - Figure B 1). The partition coefficients of the total protein, 
KProtein, were determined according to Equation 7, 
 
         
            
             
 
 
where              and               are the concentration of total protein in the PEG and 
in the salt aqueous phases, respectively. 
Possible interferences of Na2SO4 and PEGs with the analytical method were 
investigated and found to be not significant at the working conditions. As IgY is a protein 
and the aqueous solution of egg yolk is a complex matrix because it contains other 
proteins, it is not possible to calculate the specific partition coefficient of the IgY using of 
the UV-Vis data. It is possible thus, beforehand, to calculate the partition coefficient of the 
total proteins present in solution. To quantify the IgY and to determine the related 
parameters other quantification and identification techniques must be employed. 
After quantification, the protein profile of the coexisting aqueous phases was 
investigated by SDS-PAGE. 
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2.3.2.1.1. pH measurement 
The pH of both the PEG-rich and salt-rich aqueous phases were measured at  
298 K (± 1 K) using a METTLER TOLEDO SevenMulti pH meter within an uncertainty of 
± 0.02. 
 
 
2.3.2.2. ATPS composed of PEG + Na2SO4 and PEG + Na2SO4 + IL 
The buffered aqueous solution of egg yolk was prepared according the combined 
protocols described by Liu et al. and Pauly et al. [31, 65]. The ternary and quaternary 
mixtures compositions were chosen based on the phase diagrams determined before for 
each ATPS constituted by PEG-Na2SO4 and PEG-Na2SO4 with different ILs combinations. 
It should be remarked that the results obtained for the systems without IL are also 
presented in this section since the water soluble fraction obtained from egg yolk was 
obtained in a similar experimental step and are valuable for comparison purposes with the 
systems containing ILs as adjuvants. 
Each mixture was vigorously stirred and left to equilibrate for at least 12 h (a time 
period established in previous optimizing experiments) and at 298 K, to achieve the 
complete partitioning of the proteins between the two phases. Again, the PEG-rich phase is 
the top layer while the salt-rich phase corresponds to the bottom layer.  
After a careful separation the two phases, the protein content and respective partition 
coefficient (Equation 7) was determined by UV-spectroscopy, using a SHIMADZU UV-
1700, Pharma-Spec Spectrometer, at a wavelength of 280 nm. A previous calibration curve 
was established using of BSA (cf. Annex B - Figure B 1) as previously described. The 
protein profile of each aqueous phase was investigated by SDS-PAGE described below. 
Since the quaternary systems are also constituted by IL it the partitioning of the IL itself 
between the coexisting phases must be studied. The quantification of [C4mim][N(CN)2] 
was carried out by UV-spectroscopy, using a SHIMADZU UV-1700, Pharma-Spec 
Spectrometer, at a wavelength of 211 nm. Possible interferences of Na2SO4 and PEGs with 
the analytical method were investigated and found to be not significant at the dilutions 
performed for the quantification of the IL. The partition coefficient of IL, KIL, was 
determined according to Equation 8, 
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(8)     
       
        
 
 
where         and          are the concentration of IL in the PEG and in the salt aqueous 
phases, respectively. 
 
 
2.3.2.3. ATPS composed of IL + Na2SO4  
The preparation of the water-soluble fraction of egg yolk followed the same protocol 
described in section 2.3.2.2., and the final filtered aqueous solution was further employed 
in the composition of each ATPS. 
The ternary mixtures compositions were chosen based on the phase diagram already 
available in literature [66].  
Each mixture was vigorously stirred and left to equilibrate at the same conditions 
described before in section 2.3.2.2. In this type of systems, and at the compositions used, 
the top phase corresponds to the IL-rich aqueous phase whereas the salt-rich phase 
represents the bottom layer. 
After a careful separation of the two phases, the protein profiles in each aqueous 
phase were investigated by SDS-PAGE. 
 
 
2.3.2.4.  Simulation of a countercurrent chromatography process 
The preparation of the water-soluble fraction of egg yolk followed the same protocol 
described in section 2.3.2.2., and the final aqueous solution was further employed in the 
composition of each ATPS. 
The mixture was vigorously stirred and left to equilibrate at the same conditions 
described before in section 2.3.2.2. After a careful separation of the two phases, the TL of 
this ATPS was determined according to the section 2.2.2.2. Then, the phases were 
carefully separated and the bottom phase was recovered and reused to form a new ATPS 
adding the amount of PEG, PBS and [C4mim][N(CN)2] necessary to form a new biphasic 
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solution and with the same point of initial biphasic mixture. This procedure was repeated 
once again obtaining thus 3 cycles of partitioning. 
The protein profiles of all ATPS-based samples were investigated by SDS-PAGE. 
 
 
2.3.2.5. SDS-PAGE 
The protein profile of the obtained aqueous rich phases was investigated by sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). All samples were diluted 
so that the amount of protein in each gel lane was about 0.5 µg. This amount was predicted 
taking into account the UV quantification of the total amount of proteins in each phase.  
Electrophoresis was run on polyacrylamide gels (stacking: 4 % and resolving:  20 %) with 
a running buffer consisting in 250 mM Tris HCl, 1.92 M glycine, 1 % SDS. The proteins 
were stained with the usual staining procedure (Coomassie Brilliant Blue G-250 0.1 % 
(w/v), methanol 50 % (v/v), acetic acid 7 % (v/v) and water 42.9 % (v/v)) in an orbital 
shaker at a moderate speed during 2-3 hours at room temperature. The gels were distained 
in a solution containing acetic acid 7 % (v/v), methanol 20 % (v/v) and water 73 % (v/v) in 
an orbital shaker at a moderate speed during 3-4 h at room temperature. SDS-PAGE 
Molecular Weight Standards, Marker molecular weight full-range (VWR), were used as 
protein standards. All gels were analyzed using the Image Lab 3.0 (BIO-RAD) analysis 
tool. 
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3. Results and discussion  
  
43 
 
3.1. PEG + Na2SO4 + H2O ternary systems 
Novel ternary phase diagrams were determined for several PEGs (PEG 200, 300, 400 
and 600) + water + sodium sulfate, at 298 K and at atmospheric pressure. The respective 
ternary phase diagrams are illustrated in Figure 9. The experimental weight fraction data of 
each phase diagram are given at Appendix A (Table A 1 to Table A 2). 
The system composed of PEG 600, sodium sulfate and water has already been 
reported in literature and the results obtained in this work are in close agreement with 
literature data [12] (cf. Appendix A- Figure A 1). 
In the studied ATPS, the top phase corresponds to PEG-rich aqueous phase while the 
bottom phase is mainly composed of the Na2SO4 salt and water.  
Figure 9 depicts the effect of the molecular weight of PEG in the formation of ATPS. 
The solubility curves are presented in molality units for a better understanding of the 
impact of the PEGs molecular weight on the phase diagrams behavior. In the presented 
phase diagrams the biphasic region is localized above the solubility curve. The larger this 
region the higher is the ability of PEG to undergo liquid-liquid demixing in the presence of 
Na2SO4 in aqueous media.  
As expected, the influence of the length of the PEG chains on the phase diagram is 
notorious. For polymers of lower molecular weight the phase separation occurs at higher 
PEG and sodium sulfate concentrations. In general, the ability of PEG to form ATPS in the 
presence of the inorganic salt decreases in the following order: PEG 600 > PEG 400 > PEG 
300 > PEG 200. Similar trends have been observed in other ATPS composed of 
polymer/salt or PEG/IL combinations [6, 67]. This behavior is a main consequence of the 
higher hydrophobicity displayed by PEGs of higher molecular weight, i.e., they present  a 
lower affinity for water, and are more easily  salted-out by Na2SO4 [67].  
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Figure 9 - Evaluation of the molecular weight of PEG in ternary phase diagrams composed of  
PEG + Na2SO4 + H2O: PEG 600 (); PEG 400 (x), PEG 300 (); PEG 200 (). 
 
For the studied systems, the experimental binodal data were further fitted by the 
empirical relationship described by Equation 1. The regression parameters were estimated 
by the least-squares regression method, and their values and the corresponding standard 
deviations (σ) are provided in Table 4. In general, good correlation coefficients were 
obtained for all systems, indicating that these fittings can be used to predict data in a given 
region of the phase diagram where no experimental results are available. 
The experimental TLs, along with their respective length (TLLs), are reported in 
Table 5. An example of the TLs obtained is depicted in Figure 10. In general, the TLs are 
closely parallel to each other. 
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Table 4 - Correlation parameters used to describe the experimental binodal data by Equation 1. 
PEG A ± σ B ± σ 105 (C ± σ) R2 
PEG + Na2SO4 + water systems 
600 81.8 ± 0.6 -0.471 ± 0.004 20.0 ± 0.60 0.99964 
400 85.6 ± 1.4 -0.449 ± 0.007 6.10 ± 0.77 0.99891 
300 87.0 ± 1.2 -0.417 ± 0.006 6.12 ± 0.42 0.99916 
200 91.5 ± 1.7 -0,376 ± 0,008 2.74 ± 0.57 0.99896 
 
 
Table 5 - Experimental data of TLs and TLLs of PEG + Na2SO4 ATPS. 
PEG 
Weight fraction composition (wt %) 
TLL 
[PEG]PEG [salt]PEG [PEG]M [salt]M [PEG]salt [salt]salt 
600 40.36 2.23 23.87 10.09 1.62 20.72 42.93 
400 
40.06 2.86 30.05 9.96 1.31 30.35 47.51 
33.67 4.29 25.25 9.96 3.86 24.37 35.94 
36.87 3.51 26.99 10.02 3.07 25.81 40.49 
300 
32.59 5.44 19.27 13.94 6.13 22.33 31.87 
41.89 3.06 33.13 9.98 0.43 35.82 52.90 
200 40.81 4.59 33.17 9.92 6.54 28.50 41.79 
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Figure 10 - Phase diagram for the ternary system composed of PEG 400 + Na2SO4 + H2O: binodal curve data 
(); TL data (); adjusted binodal data through Equation 1 (-). 
 
 
3.2. PEG + Na2SO4 + H2O + IL quaternary systems 
Figure 11 and Figure 12 present the experimental phase diagrams at 298 K and 
atmospheric pressure for each PEG + Na2SO4 + H2O + IL system. The experimental 
weight fraction data of each phase diagram are given at Appendix A (Table A 3 to Table A 
5). It should be pointed out that the IL concentration was kept constant in all the phase 
diagrams determination. The binodal curves are reported in molality units for an enhanced 
understanding on the impact of distinct ILs in the formation of ATPS.  
Figure 11 shows the influence of  [C4mim]-based ILs, and thus of the IL anion nature, 
on the phase diagrams behavior, where results for [C4mim][TOS], [C4mim][SCN], 
[C4mim][CH3CO2] and [C4mim][N(CN)2] are depicted. In Figure 11 the phase diagram for 
the control system without IL is further represented for comparison purposes. In all the 
studied examples, the presence of  IL facilitates the phase separation since all the biphasic 
regions are larger in the presence of IL when compared with the control system. The IL 
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anion ability to form ATPS is as follows: [CH3CO2]
-
 < [TOS]
-
 < [N(CN)2]
-
 ≈ [SCN]-. 
There is a decrease on the ATPS formation ability with the increase in the IL anion affinity 
for water, following the trend of the anion hydrogen bond basicity [12]. Thus, the 
hydrophobicity of the IL anion or its ability to hydrogen-bond with water controls the 
ATPS formation [12]. 
 
 
Figure 11 - Phase diagrams for the quaternary systems composed of PEG + Na2SO4 + H2O + IL at 298 K: no 
IL (); [C4mim][CH3CO2] (); [C4mim][TOS] (); [C4mim][N(CN)2] (); [C4mim][SCN] (+). 
 
In order to evaluate the effect of the IL concentration on the phase diagrams 
behavior, the binodal curves of the systems composed of  PEG  + Na2SO4 + H2O +  
 two concentrations of [C4mim][N(CN)2] were determined. Figure 12 shows the respective 
phase diagrams together with the control system without IL. In general, the higher the 
amount of IL the higher is the ability for two-phases formation. In summary, higher 
amounts of IL in the quaternary system leads to TLs or phases compositions with a higher 
water content which can be favorable for the extraction of proteins, and in this particular 
work, of antibodies.  
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Figure 12 - Phase diagrams for the systems composed of PEG + Na2SO4 + H2O + IL at 298 K: no IL (); 
lower amount of [C4mim][N(CN)2] (); higher amount of  [C4mim][N(CN)2] (). 
 
Since a higher amount of IL improves the phase separation, the effect of the IL cation 
core and alkyl side chain length was further investigated fixing this amount of IL in the 
quaternary system. The respective phase diagrams are depicted in Figure 13 with results 
for [C4mim][N(CN)2], [C2mim][N(CN)2] and [C4mpy][N(CN)2].  The IL cation ability to 
form ATPS is as follows: [C2mim]
+
 < [C4mim]
+
 ≈ [C4mpy]
+
. This trend reflects the 
capacity of the IL cation to be solvated by water (since the dicyanamide anion is the 
counterion common to all ILs), and which is regulated by steric and entropic contributions 
[68-70]. The trend obtained here is in agreement with the results previously reported for 
IL-based ATPS composed of different salts [69]. 
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Figure 13 - Phase diagrams for the dicyanamide-based quaternary systems composed of PEG + Na2SO4 + 
H2O + IL at 298 K: no IL (); [C4mim][N(CN)2] (); [C2mim][N(CN)2] ();  
[C4mpy][N(CN)2] (). 
 
For all the studied systems, the experimental binodal data were also fitted by the 
empirical relationship described by Equation 1. The regression parameters were estimated 
by the least-squares regression method, and their values and corresponding standard 
deviations (σ) are provided in Table 6. In general, highly satisfactory correlation 
coefficients were obtained for all systems. 
The experimental TLs, along with their respective length (TLLs), are reported in 
Table 7. An example of the TLs obtained is depicted in Figure 14. As observed with the 
systems without IL, the TLs are closely parallel to each other. 
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Table 6 - Correlation parameters used to describe the experimental binodal data by Equation 1. 
IL A ± σ B ± σ 105 (C ± σ) R2 
PEG + Na2SO4 + water + IL system 
[C4mim][TOS] 80.4 ± 1.7 -0.420 ± 0.009 15.70 ± 0.66 0.99927 
[C4mim][SCN] 92.5 ± 1.0 -0.497 ± 0.006 14.66 ± 0.99 0.99966 
[C4mim][CH3CO2] 91.6 ± 1.4 -0.461 ± 0.008 2.09 ± 0.56 0.99946 
[C4mim][N(CN)2] 81.8 ± 1.4 -0.442 ± 0.008 19.39 ± 0.80 0.99925 
PEG + Na2SO4 + water + IL system 
[C4mim][N(CN)2] 93.3 ± 1.4 -0.5688 ± 0.014 35.65 ± 2.84 0.99864 
[C2mim][N(CN)2] 100.1 ± 1.5 -0.569 ± 0.008 14.17 ± 1.22 0.99948 
[C4mpy][N(CN)2] 102.1 ± 3.7 -0.615 ± 0.024 6.28 ± 11.19 0.99520 
 
 
Table 7 - Experimental data of TLs and TLLs of PEG 300 + Na2SO4 + 5/10 wt % IL ATPS. 
Weight fraction composition (wt %) 
IL [PEG]PEG [salt]PEG [PEG]M [salt]M [PEG]salt [salt]salt TLL 
[C4mim][TOS] 34.16 4.06 16.94 15.46 0.53 26.31 40.32 
[C4mim][SCN] 
39.05 2.98 30.01 9.991 0.02 33.23 49.38 
38.70 3.04 17.11 15.00 1.12 23.85 42.96 
[C4mim][N(CN)2] 
44.64 2.08 32.97 10.05 0.01 32.54 54.04 
43.23 2.30 30.94 10.19 0.01 30.02 51.31 
38.00 2.97 17.16 15.00 0.51 24.61 43.29 
39.86 2.62 10.00 20.15 0.31 25.84 45.87 
IL [PEG]PEG [salt]PEG [PEG]M [salt]M [PEG]salt [salt]salt TLL 
[C4mim][N(CN)2] 
29.98 3.84 19.78 10.12 0.11 22.23 35.08 
31.83 3.48 10.00 20.13 0.00 27.76 40.04 
[C4mpy][N(CN)2] 35.23 2.99 24.99 9.99 1.44 26.11 40.95 
[C2mim][N(CN)2] 
38.00 2.88 34.95 5.04 0.11 29.66 46.39 
27.9 4.91 19.95 10.02 1.64 21.75 31.22 
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Figure 14 - Phase diagram for the quaternary system composed of PEG + Na2SO4 + H2O +  
[C4mim][N(CN)2]: binodal curve data (•); TL  data (); adjusted binodal data through  
Equation 1 (-). 
 
All the phase diagrams presented before were determined with aqueous solutions 
using ultra-pure water as the main solvent. However, and according the optimized protocol 
of purification of IgY described in section 2.3.2.2., the aqueous solution of egg yolk was 
initially prepared with PBS. Thus, novel ternary and quaternary phase diagrams were 
determined with aqueous solutions of PBS instead of pure water, at  
298 K and at atmospheric pressure. These novel phase diagrams were determined to infer 
on the influence of PBS through the phase diagrams behavior. The experimental weight 
fraction data of each phase diagram are given at Appendix A (Table A 6 to Table A 7). The 
respective ternary phase diagrams are illustrated in Figures 15 and 16. 
Figure 15 compare the PEG + Na2SO4 + H2O ternary diagram with the  
PEG + Na2SO4 + water + PBS ternary diagram. As shown both phase diagrams are 
overlapping which means that the presence of the saline solution doesn’t significantly 
influence the phase diagram and consequently the ATPS used for the IgY partitioning 
studies. 
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Figure 16 compares the PEG + Na2SO4 + H2O + [C4mim][N(CN)2] quaternary 
diagram with the PEG  + Na2SO4 + water + PBS + [C4mim][N(CN)2] diagram. As 
observed before, the presence of the “extra” saline solution doesn’t influence the phase 
diagram behavior and consequently the phases compositions used in the partitioning 
investigations. 
 
 
Figure 15 - Evaluation of the presence of PBS in phase diagrams for the ternary systems composed of PEG + 
Na2SO4 + H2O () or PBS (). 
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Figure 16 - Evaluation of the presence of PBS in phase diagrams for the quaternary systems composed of 
PEG + Na2SO4 + [C4mim][N(CN)2] + H2O  () or PBS (). 
 
 
3.3. Purification of IgY using ATPS  
3.3.1. ATPS composed of PEG + Na2SO4 
In Figure 17 it is presented the macroscopic appearance of the ternary mixtures with 
the compositions described in Table 8. It is clear that these mixtures and the preparation 
procedure are not appropriate for the purification of IgY since there is always an 
intermediate solid-like phase. The generation of this intermediate phase suggests that some 
proteins present in the aqueous solution of the water-soluble fraction of egg yolk suffer 
denaturation. In these preliminary studies the pH was slightly acidic (pH of the phases is 
circa 3.5 for ATPS with PEG 600, 4.0 for ATPS with PEG 400 and 6.0 for ATPS with 
PEG 300 according to pH measurements carried out in the separated phases) due to the 
absence of a buffered solution. All of these pH values are below the isoeletric point of 
some proteins in the medium (IgY, -livetin, has a pI between 5.7 and 7.6 and β-livetin has 
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a pI around 5) [25]. Moreover, it is notorious that PEGs of higher molecular weight lead to 
a larger amount of denaturated proteins. Besides the higher molecular weight of PEG that 
turns it into a more hydrophobic substance, this fact also seems to be related with the pH of 
each PEG solution. In other words, higher molecular weight PEGs result in aqueous 
solutions of lower pH values which lead to the proteins denaturation.  
 
 
Figure 17 - ATPS formed by PEG + Na2SO4 + aqueous solution of egg yolk. 
 
Table 8 - Mixture points of ATPS composed of PEGs of different molecular weight for the purification of IgY 
using the aqueous solution of egg yolk containing the water-soluble proteins. 
ATPS Identification 
Mw of PEG   
(g·mol-1) 
[PEG]  
(wt %) 
[Na2SO4]  
(wt %) 
[Aqueous Solution] 
(wt %) 
1 200 33 10 57 
2 300 33 10 57 
3 400 27 10 63 
4 600 24 10 66 
 
Despite the fact that a solid phase was always present in the investigated systems, the 
aqueous phases were separated to ascertain on the amount of total proteins present in each 
phase. The results obtained for the partition coefficients of the total proteins in the 
preliminary ATPS with an uncontrolled pH are shown in Figure 18. The partition 
coefficients of the systems formed by 33 wt % PEG 200 + 10 wt % Na2SO4 is not 
presented since when separating the coexisting phases (top and bottom) they immediately 
crystallized. The total amount of proteins in the systems composed of  
PEG 300, PEG 400 and PEG 600, is 0.013 g, 0.016 g and 0.002 g, respectively. Indeed, 
these values closely correlate with the macroscopic appearance of the ATPS shown in 
55 
 
Figure 17. The ATPS with the PEGs of higher molecular weight lead to a more intense 
precipitation of proteins, and thus, the total amount of proteins in solution is lower. 
The partition coefficients of the total proteins range between 27.2 and 0.4 and are 
highly dependent on the molecular weight of the PEG used. In general, an increase in the 
molecular weight of PEG leads to a lower partitioning of the proteins for the polymer-rich 
phase. Water-soluble proteins prefer more hydrated phases, and thus, the increase of the 
molecular weight of PEG leads to more hydrophobic phases which are not “preferred” by 
the water-soluble proteins present in egg yolk [6]. PEGs of lower molecular weight favor 
the migration of proteins for the polymer-rich phase. 
 
The SDS-PAGE of ATPS 2, 3 and 4 was also carried out to identify the major 
proteins in solutions. However, the gel didn’t show any bands. Therefore, it is impossible 
to present any protein profile for these mixtures. The main problem could be the low 
concentration of proteins in the samples prepared. It should be noted that in these mixtures 
it was macroscopically observed the denaturation of some proteins. Therefore, since the 
precipitation of proteins was observed in this type of mixtures, no additional tests were 
conducted and the procedure of using buffered solutions was further adapted. 
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Figure 18 - Partition coefficients of total protein in ATPS formed by PEG + Na2SO4 + H2O at 298 K. 
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3.3.2. ATPS composed of PEG + Na2SO4 and PEG + Na2SO4 + IL 
The macroscopic appearance of the ATPS formed, now using the PBS buffer and the 
preliminary precipitation step, is shown in Figure 19. By adopting these procedures the 
denaturation of proteins was decreased or even completely avoided as the solid-like phase 
is now not visible.  
 
 
Figure 19 - ATPS formed by PEG + Na2SO4 + buffered aqueous solution of egg yolk.  
 
Table 9 - Mixture points of PEG-based ATPS for the purification of IgY using the buffered aqueous solution 
of egg yolk containing the water-soluble proteins. 
ATPS Identification Mw of PEG (g·mol-1) 
[PEG]  
(wt %) 
[Na2SO4]  
(wt %) 
[Aqueous Solution]  
( wt %) 
5 200 22 14 64 
6 300 19 14 67 
7 300 17 15 68 
8 300 10 20 70 
9 400 16 14 70 
 
The results obtained for the partition coefficients of total protein in the several ATPS 
with a controlled pH (~7) in the aqueous media are shown in Figure 20. The partition 
coefficients of total protein range between 3.2 and 18.5. As observed before with the ATPS 
where no control of the pH value was carried out, an increase in the molecular weight of 
PEG leads to lower partition coefficients. However, an exception is now observed with 
PEG 200 where the partition coefficient of total protein of ATPS 5 (22 wt % PEG 200 + 14 
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wt % Na2SO4 + 64 wt % buffered aqueous solution of egg yolk) is lower than in ATPS 6 
(19 wt % PEG 300 + 14 wt % PEG 200 + 67 wt % buffered aqueous solution of egg yolk).  
Comparing the results of the partition coefficients of total protein in ATPS using the 
buffered or non-buffered aqueous solutions of egg yolk it is visible that the buffered media 
lead to a decrease in the partition coefficients of ATPS composed of PEG 300 or PEG 400. 
In addition, the total amount of protein in each system is 0.080 g, 0.031 g and 0.047 g for 
the systems composed of PEG 200, PEG 300 and PEG 400, respectively. Therefore, these 
values confirm the precipitation of protein as observed before where no control of the 
medium pH was carried out. The high content of proteins is thus related with the absence 
of an intermediate phase with denaturated proteins and with the precipitation of the high 
molecular weight lipoproteins. The first reason allows the proteins to choose “better” the 
phase for which they have more affinity whereas the second reason decreases the total 
amount of contaminant proteins. Curiously, using the buffered medium it was not observed 
the crystallization of the coexisting phases of the system composed of PEG 200 as 
observed before. 
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Figure 20 - Partition coefficients of total protein in ATPS formed by PEG + Na2SO4 + H2O at 298 K. 
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The protein profiles obtained from SDS-PAGE of the egg yolk buffered aqueous 
solution, as well as of the coexisting phases of the ATPS composed of PEGs + Na2SO4 + 
buffered aqueous solution of egg yolk are shown in Figure 21. The commercial pure IgY, 
under reducing conditions, presents two major bands at 65 kDa and 25 kDa that correspond 
to two heavy chains and two light chains, respectively. In sample (A) these two bands are 
visible whereas in samples (B), (C), (D), (F), (G) and (H) only the heavy chain around 65 
kDa is detectable.  In all samples, with the exception of sample (E) where no proteins at all 
were detected possibly due to their low concentration, another significant band around 38 
kDa, and that corresponds to β-livetin, a contaminant protein of the water-soluble proteins 
present in egg yolk, is always visible.  
The absence of any band in sample (E) may be explained by a sample dilution higher 
than necessary or because all proteins in the aqueous solution are preferentially migrating 
to the top phase of the ATPS. This trend is plausible taking into account the high total 
protein partition coefficient values reported in Figure 20.  Despite the bottom phase of the 
ATPS constituted by PEG 300, lane (E), seems to present no detectable amounts of 
proteins, this PEG is indeed the more efficient amongst the evaluated ones because in the 
top phase, lane (D), the band corresponding to β-livetin is not as evident as in the other top 
phases, lane (B) and lane (F), meaning that the main contaminant is being retained in the 
opposite phase. 
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Figure 21 - SDS-PAGE of a gel loaded with 0.5 µg of protein/well stained with Coomassie blue. 
Lane 1 (Std): Standard molecular weights; 
Lane 2 (Pure IgY): Commercial and pure IgY from chicken egg yolk from by Sigma-
Aldrich®; 
Lane 3 (A):  Buffered egg yolk aqueous solution; 
Lane 4 (B): and Lane 5 (C): Top and bottom phases, respectively, of the ATPS constituted 
by 22 wt % PEG 200 + 14 wt % Na2SO4; 
Lane 6 (D) and Lane 7 (E): Top and bottom phases, respectively, of the ATPS constituted 
by 19 wt % PEG 300 + 14 wt % Na2SO4; 
Lane 8 (F) and Lane 9 (G): Top and bottom phases, respectively, of the ATPS constituted 
by 16 wt % PEG 400 + 14 wt % Na2SO4. 
 
As all the samples present contaminant proteins, from now on the partition 
coefficients of the total proteins will not be displayed because, at this stage, they do not 
provide any specific information regarding the selective migration of IgY.   
Since the best results were obtained with the ATPS composed of PEG, PEG-based 
ATPS with ILs as adjuvants were further used to evaluate the tailoring ability of diverse 
ILs on the selective extraction of IgY. The IL was used at small concentrations. Table 10 
presents the ATPS identification. 
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Table 10 – ATPS identification. 
ATPS Identification Polymer IL Identification [IL] (wt %) 
10 PEG [C4mim][TOS] 5.0 
11 PEG [C4mim][SCN] 5.0 
12 PEG [C4mim][CH3CO2] 5.0 
13 PEG [C4mim][N(CN)2] 5.0 
14 PEG [C4mim][N(CN)2] 5.0 
15 PEG [C4mim][N(CN)2] 5.0 
16 PEG [C4mim][N(CN)2] 1.0 
17 PEG [C4mim][N(CN)2] 10.0 
18 PEG [C4mim][N(CN)2] 10.0 
19 PEG [C2mim][N(CN)2] 5.0 
20 PEG [C6mim][N(CN)2] 5.0 
21 PEG [THTDP][N(CN)2] 5.0 
22 PEG [C4mpy][N(CN)2] 10.0 
23 PEG [C4mim][C(CN)3] 10.0 
24 PEG [C4mim][SCN] 10.0 
 
Figure 22 shows the macroscopic appearance of the ATPS containing the buffered 
egg yolk solution, PEG, Na2SO4 and each IL. For the ILs [C4mim][TOS] and 
[C4mim][N(CN)2]  it don’t exist the formation of an intermediate phase as observed in the 
preliminary tests when using a non-buffered egg yolk aqueous solution. On the other hand, 
for the ILs [C4mim][SCN] and [C4mim][CH3CO2], there is the precipitation and/or 
denaturation of proteins. [C4mim][CH3CO2] is composed of a highly hydrophilic anion 
with a salting-out effect which could leads to the precipitation of proteins (according to the 
Hofmeister series) [71]. Therefore, the ATPS with [C4mim][CH3CO2] was immediately 
discarded and not used in the following experiments. Albeit some precipitation was also 
observed with the ATPS constituted by [C4mim][SCN], this was used in some following 
experiments to address on the effect through the IgY purification by the number of –CN 
groups at the anion.  
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Figure 22 - ATPS formed by PEG + Na2SO4 + 5 wt % IL. 
 
Figure 23 depicts the SDS-PAGE results or protein profile of samples from ATPS 10 
and 14 formed by PEG + Na2SO4 + 5 wt % of [C4mim][TOS] or [C4mim][N(CN)2], 
respectively.   
 In all ATPS-based samples the heavy chain of IgY is visible as well as the main 
impurity β-livetin. Particularly relevant, and seen in lanes (C) and (D) that belong to ATPS 
13, that have in its composition [C4mim][N(CN)2], is that IgY and β-livetin are displaying 
different affinities for the coexisting phases. The IgY has more affinity to the bottom phase 
(Na2SO4-rich aqueous phase) of the corresponding PEG-based ATPS and the β-livetin has 
enhanced affinity for the corresponding top phase (PEG-rich aqueous phase) as revealed by 
the intensity of the bands. This protein profile shows that the presence of [C4mim]N(CN)2] 
leads to a preferential affinity of β-livetin to the top phase. As a result it seems that the IL 
is promoting the β-livetin migration for the top phase while leaving the γ-livetin (IgY) in 
the opposite phase. 
 Comparing the protein profile in the ATPS without IL (Figure 21) and with IL 
(Figure 23) it’s clearly demonstrated that the presence of IL improves the selective 
separation of IgY and β-livetin for different phases. 
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Figure 23 - SDS-PAGE of a gel loaded with 0.5 µg of protein/well, stained with Coomassie blue. 
 Lane 1 (Std): Standard molecular weights; 
Lane 2 (Pure IgY): Commercial and pure IgY from chicken egg yolk from by Sigma-
Aldrich®; 
Lane 3 (A) and Lane 4 (B): Top and bottom phases, respectively, of the ATPS constituted by 
PEG + Na2SO4 + [C4mim][TOS];  
Lane 5 (C) and Lane 6 (D): Top and bottom phases, respectively, of the ATPS constituted by 
PEG + Na2SO4 + [C4mim][N(CN)2]. 
 
Aiming at concentrating the major contaminant into the top phase, the amount of 
PEG was decreased while increasing the amount of Na2SO4, ATPS 14 and 15. The idea 
was to maintain the same phase compositions and to manipulate the concentration of β-
livetin in the top phase. The last ATPS, with the higher concentration of the inorganic salt 
was impossible to create because the salt didn’t solubilized completely and a solid phase 
was always present. Therefore, concentrations above 25 wt % were discarded and not used 
in the following experiments.  
Figure 24 displays the protein profile in the ATPS 13 and ATPS 15 to compare the 
results obtained previously and the results increasing the amount of salt. In this figure it is 
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seen the prominent presence of β-livetin in band (C). These results are as expected and 
confirm the idea that β-livetin has more affinity to the top phase, the PEG-rich phase, and 
the amount of contaminant protein increased as revealed by the higher intensity of the band 
corresponding to β-livetin. The absence of any band in sample (B) may be explained by the 
increased amount of inorganic salt in the initial mixture that leads to a phase with more 
water. As desired and comparing the two protein profiles it can be seen that increasing the 
concentration of salt leads to the concentration of the major contaminant into the top phase. 
 
 
Figure 24 - SDS-PAGE of a gel loaded with 0.5 µg of protein/well, stained with Coomassie blue. 
Lane 1 (Std): Standard molecular weights; 
Lane 2 (Pure IgY): Commercial and pure IgY from chicken egg yolk from by Sigma-
Aldrich®; 
Lane 3 (A) and Lane 4 (B): Top and bottom phases, respectively, of the ATPS constituted by 
PEG + Na2SO4 + [C4mim][N(CN)2]; 
Lane 5 (C) and Lane 6 (D): Top and bottom phases, respectively, of the ATPS constituted by 
PEG + Na2SO4 + [C4mim][N(CN)2]. 
 
Because the presence of IL, and particularly of [C4mim][N(CN)2], increases the 
affinity of β-livetin for the top phase, the weight percentage of IL added was studied with 
the ATPS 16 and 17. These ATPS have in their constitution fixed amounts of PEG and 
Na2SO4, because it was previously shown that with these values it was possible to properly 
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concentrate β-livetin, and different amount of ILs. Figure 25 shows the macroscopic 
appearance of the ATPS 15, 16 e 17 that contain different concentrations of 
[C4mim][N(CN)2]. For ATPS 15 and 16, there is no formation of an intermediate phase, 
while in ATPS 17 there is the precipitation and/or denaturation of a considerable amount of 
proteins. These results suggest that higher concentrations of IL favor the formation of an 
intermediate phase composed of denatured protein and are not favorable for the envisaged 
extraction and purification technique. Despite the significant amounts of proteins 
precipitated in ATPS 17, the two liquid phases were separated for all ATPS and examined 
by SDS-PAGE. 
 
 
Figure 25 - ATPS formed by PEG + Na2SO4 + [C4mim][N(CN)2]. 
 
 Figure 26 depicts the protein profile of the ATPS with variable concentrations of 
IL. In all the ATPS-based samples the impurity β-livetin remains visible whereas the heavy 
and light chains of IgY are only visible in some systems. IgY and β-livetin still have 
different affinities for the coexisting phases in the presence of different concentrations of 
[C4mim][N(CN)2] as revealed by the intensity of the bands. In lane (A), that corresponds to 
the top phase with [C4mim][N(CN)2], and as has been previosly shown, the band 
corresponding to β-livetin has higher intensity than the band corresponing to the heavy 
chain of IgY. In lane (C) that corresponds to the top phase of the ATPS with a lower 
amount of [C4mim][N(CN)2], despite the existence of  a large amount of β-livetin, the band 
of the heavy chain of IgY is still visible, meaning that the selective separation is not so 
effective at low concentrations of IL. In lane (E) that belongs to ATPS 17, only  β-livetin is 
visible. The absence of any band of IgY in this sample means that increasing the 
concentration of IL favors the separation of the two proteins. It is thus clearly demonstrated 
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that an increased amount of IL favors the selective separation of IgY and β-livetin. 
However, it should be remarked that in the bottom phases of all ATPS (ATPS 14, 16 and 
17) the band of IgY does not appear, unlike expected maybe due to the  high concentration 
of Na2SO4 (20 wt %) used at this point that dilutes the respective phase. 
Because the bottom phase might be very diluted, this phase was concentrated by 
decreasing the amount of Na2SO4 and increasing the content of PEG, yet maintaining the 
concentration of IL at 10 wt %). Although some precipitation of proteins was observed 
with 10 wt % of IL, the best results in terms of selective extraction were precisely obtained 
with this amount of IL, and thus, it was used in the following experiments.   
 
 
Figure 26 - SDS-PAGE of a gel loaded with 0.5 µg of protein/well, stained with Coomassie blue. 
Lane 1 (Std): Standard molecular weights; 
Lane 2 (Pure IgY): Commercial and pure IgY from chicken egg yolk from by Sigma-
Aldrich®; 
Lane 3 (A) and Lane 4 (B): Top and bottom phases, respectively, of the ATPS constituted 
by PEG + Na2SO4 + [C4mim][N(CN)2];  
Lane 5 (C) and Lane 6 (D): Top and bottom phases, respectively, of the ATPS constituted 
by PEG + Na2SO4 + [C4mim][N(CN)2]; 
Lane 7 (E) and Lane 8 (F): Top and bottom phases, respectively, of the ATPS constituted 
by PEG + Na2SO4 + [C4mim][N(CN)2]. 
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 Figure 27 exhibits the protein profile of ATPS 18. It can be seen that in lanes (A) and 
(B), top and bottom phases, IgY and β-livetin are present. Therefore, in this ATPS, the 
selective separation of proteins for each phase decreases compared with ATPS 17. As in 
this ATPS the concentration of salt was decreased aiming at concentrating the IgY in the 
bottom phase, but the concentration of IL was mantained, it means that the concentration 
of salt influences also the partition behavior of proteins. In lane (A), top phase, the 
concentration of both proteins are higher than in lane (B), bottom phase, as revealed by the 
intensity of the bands. This fact might happen because the IL is majorly concentrated in the 
PEG-rich phase (top phase) increasing therefore the affinity of both proteins for that layer 
since both proteins have similar characteristics (IgY is a livetin too). 
 
 
Figure 27 - SDS-PAGE of a gel loaded with 0.5 µg of protein/well, stained with Coomassie blue. 
Lane 1 (Std): Standard molecular weights; 
Lane 2 (Pure IgY): Commercial and pure IgY from chicken egg yolk from by Sigma-
Aldrich®; 
Lane 3 (A) and Lane 4 (B): Top and bottom phases, respectively, of the ATPS constituted by 
PEG + Na2SO4 + [C4mim][N(CN)2]. 
 
Since decreasing the concentration of Na2SO4 didn’t result in a better selective 
separation of IgY and of the major contaminant protein (β-livetin), and the best results so 
far were achieved with PEG, Na2SO4 and higher amounts of [C4mim][N(CN)2], this point 
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of mixture was applied to form other ATPS, where the IL was changed to study the effects 
of  the IL cation while maintaining the [N(CN)2] anion. For this purpose, four new ATPS 
were prepared with different ILs: [C2mim][N(CN)2], [C6mim][N(CN)2], 
[THTDP][N(CN)2] and [C4mpy][N(CN)2] (ATPS 19, 20, 21 and 22). These ILs allow the 
evaluation of the IL cation core and alkyl side chain length influence on the selective 
separation of IgY from β-livetin. For these ATPS (ATPS 19, 20 and 21 which correspond 
to [C2mim][N(CN)2], [C6mim][N(CN)2]  and [THTDP][N(CN)2],  respectively), the 
concentration of IL was kept at a low concentration to avoid the precipitation and 
denaturation of proteins. For ATPS 22 that have in its composition [C4mpy][N(CN)2] it 
was possible to maintain the IL at a higher concentration without observing proteins 
precipitation. Figure 28 exposes the macroscopical appearance of ATPS with 
[C2mim][N(CN)2], [C6mim][N(CN)2], [THTDP][N(CN)2] and [C4mpy][N(CN)2]. A 
significant amount of denatured proteins is present in the ATPS with [THTDP][N(CN)2] 
(Figure 28-(C)). Hence, this ATPS was discarded and not used in the following 
experiments. The main reason should be associated to the high hydrophobicity displayed 
by the quaternary phosphonium cation with relatively long aliphatic chains. The ATPS 
formed with [C2mim][N(CN)2] and [C6mim][N(CN)2] also show a thin intermediate phase 
of denatured protein and [C4mpy][N(CN)2] didn’t show any visible denaturated protein. 
Since [THTDP][N(CN)2] and [C6mim][N(CN)2] are the most hydrophobic ILs investigated 
it seems that the best results are achieved with an IL with an intermediate hydrophobic 
character, such as [C2mim][N(CN)2], [C4mim][N(CN)2] or [C4mpy][N(CN)2]. 
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Figure 28 - ATPS formed by PEG + Na2SO4 + IL. 
 
The protein profiles in the ATPS with [C2mim][N(CN)2], [C6mim][N(CN)2] and 
[C4mpy][N(CN)2] are depicted in Figure 29. In general, in the three ATPS there is a similar 
protein profile. The β-livetin is in higher concentrations in the top phase, (lanes (A), (C) 
and (E)) as revealed by the intensity of the corresponding bands. However, no proteins 
were detected at the bottom phases because the samples were more diluted than necessary. 
However, major conclusions can be drawn without the need of repeating these partitioning 
experiments. Two differences can be seen in the protein profiles of lane (C) and lane (E). 
In lane (C), that correspond to the top phase of ATPS with [C2mim][N(CN)2], there is a 
totally absence of IgY and, in lane (C), belonging to the ATPS with [C4mpy][N(CN)2], it 
can be seen the band corresponding to IgY which means that this IL is not so effective in 
the selective separation of IgY from β-livetin. Thereby, [C2mim][N(CN)2] was more 
efficient than [C4mpy][N(CN)2] and [C4mim][N(CN)2] (Figure 26) In summary, it is clear 
that ILs composed of the [N(CN)2]
-
 anion provide the best results combined with 
imidazolium-based cations afford the best separation performances. 
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Figure 29 - SDS-PAGE of a gel loaded with 0.5 µg of protein/well, stained with Coomassie blue. 
Lane 1 (Std): Standard molecular weights; 
Lane 2 (Pure IgY): Commercial and pure IgY from chicken egg yolk from by Sigma-
Aldrich®; 
Lane 3 (A) and Lane 4 (B): Top and bottom phases, respectively, of the ATPS constituted by 
PEG + Na2SO4 + [C2mim][N(CN)2]; 
Lane 5 (C) and Lane 6 (D): Top and bottom phases, respectively, of the ATPS constituted by 
PEG + Na2SO4 + [C6mim][N(CN)2]; 
Lane 7 (E) and Lane 8 (F): Top and bottom phases, respectively, of the ATPS constituted by 
PEG + Na2SO4 + [C4mpy][N(CN)2]. 
 
According to the results shown in Figure 28 and Figure 29 the ATPS with an IL with 
an imidazolium cation and a -CN-based anion revealed the best results so far. Thus, novel 
ATPS composed of ILs with the common [C4mim]
+
 cation and several  
-CN-based ILs were prepared, namely ATPS 23 and 24. In ATPS 23 it was used a “new” 
IL, [C4mim][C(CN)3], whereas in ATPS 24, it was used an IL applied before, 
[C4mim][SCN]. Nevertheless, better results are now observed due to an adjustment of the 
mixture composition.  
For a better comparison of all the ILs, the ATPS 17 with [C4mim][N(CN)2] was 
prepared again and novel results were acquired to confirm the initial data.  
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The macroscopic appearances of the prepared ATPS are shown in Figure 30. As can 
be seen, increasing the number of -CN groups leads to a decreased formation of an 
intermediate phase (lower amounts of denaturated proteins). Although, based on Figure 31, 
these results didn’t influence positively the separation of β-livetin and IgY. The lanes (A) 
and (B) corresponding to ATPS with [C4mim][C(CN)3] (IL with the higher number of -CN 
groups) don’t show any band at all. This fact is indeed not expected because the mixture 
point is the same for all ATPS and the problem of dilution cannot be considered in this 
case. By now, the only explanation can be associated to the IL that does not allow, or 
interferes with the use of the SDS-PAGE. Comparing the two other ATPS, in Figure 31, 
the ATPS with [C4mim][N(CN)2], lanes  (C) and (D) (top and bottom phases), leads to 
better results than the ATPS with [C4mim][SCN], lanes (E) and (F) (top and bottom 
phase). The selective separation of IgY from its major contaminant is of better 
performance with [C4mim][N(CN)2] because, in the top phase, lane (A), there is a higher 
concentration of β-livetin, while, in the bottom phase, lane (B), there is a higher 
concentration of IgY. In the ATPS with [C4mim][SCN] the selective separation is not so 
effective. In the top phase, lane (E), the band corresponding to β-livetin is intense, whereas, 
in the bottom phase, lane (F), the intensity of the band of IgY is equal or maybe lower than 
the band of β-livetin. Thus, despite the not very favorable macroscopic appearance of the 
ATPS shown in Figure 30, the ATPS with [C4mim][N(CN)2] as adjuvant is the most 
effective on the selective partition of IgY and the contaminant protein for opposite phases. 
However, and based on all ATPS studied throughout this work, [C2mim][N(CN)2] proved 
be the most effective IL on the partition of IgY and β-livetin. 
 
  
Figure 30 - ATPS formed by PEG + Na2SO4 + IL. 
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Figure 31 - SDS-PAGE of a gel loaded with 0.5 µg of protein/well, stained with Coomassie blue. 
Lane 1 (Std): Standard molecular weights; 
Lane 2 (Pure IgY): Commercial and pure IgY from chicken egg yolk from by Sigma-
Aldrich®; 
Lane 3 (A) and Lane 4 (B): Top and bottom phases, respectively, of the ATPS constituted by 
PEG + Na2SO4 + [C4mim][C(CN)3];  
Lane 5 (C) and Lane 6 (D): Top and bottom phases, respectively, of the ATPS constituted by 
PEG + Na2SO4 + [C4mim][N(CN)2]; 
Lane 7 (E) and Lane 8 (F): Top and bottom phases, respectively, of the ATPS constituted by 
PEG + Na2SO4 + [C4mim][SCN]. 
 
 
3.3.3. ATPS composed of IL + Na2SO4 
The results obtained so far with PEG-based ATPS suggest that the presence of some 
ILs as adjuvants increases the affinity of the major contaminant protein, β-livetin, for the 
top phase while retaining the IgY in the bottom phase. Since the best results were obtained 
with [N(CN)2]-based ILs, an IL-based ATPS already reported in literature [66], without 
PEG and composed only of [C4mim][N(CN)2] and Na2SO4 was tested. The phase diagrams 
for this type of IL-based ATPS are already published in literature and the biphasic regions 
were chosen according to these published data [66]. Three mixture compositions were 
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prepared, namely ATPS 25, 26 and 27 according to data previously published [66] – and 
increasing the amount of IL while decreasing the amount of salt. 
The macroscopic appearance of three prepared ATPS is shown in Figure 32. In 
general, an increase in the IL content leads to a higher amount of denatured proteins. 
 
 
Figure 32 - ATPS formed by   IL + Na2SO4 + aqueous solution of egg yolk buffered with progressively 
higher amounts of IL and lower amounts of salt. 
 
Figure 33 exhibits the protein profile observed in each phase of the IL-based ATPS. 
Lanes (A) and (B) belong to ATPS 26. In these lanes it can be seen that β-livetin has more 
affinity to the top phase, lane (A), like previously observed in PEG-based ATPS where the 
same IL was used as adjuvant. On the other hand, the bottom phase must be too much 
diluted and no proteins are detected at all.  
For ATPS 26, IgY also migrates to the top phase together with most part of β-livetin 
(lane C). Moreover, some β-livetin also starts to migrate to the bottom phase, lane (D), and 
meaning that, in general, the selective separation is becoming worst. With the subsequent 
increasing of IL, ATPS 27, the IgY still continues to show preferential affinity to top phase 
while half of the amount of β-livetin migrates to the top phase and the other half migrates 
to the bottom phase. 
By the results depicted in Figure 33 it is clear that the affinity of both proteins 
changed with different concentrations of IL in the ATPS. With the increase of the IL 
content there is a reduction on the selective partitioning of IgY and β-livetin for opposite 
phases. 
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Figure 33 - SDS-PAGE of a gel loaded with 0.5 µg of protein/well, stained with Coomassie blue. 
Lane 1 (Std): Standard molecular weights; 
Lane 2 (Pure IgY): Commercial and pure IgY from chicken egg yolk from by Sigma-
Aldrich®; 
Lane 3 (A) and Lane 4 (B): Top and bottom phases, respectively, of the ATPS constituted by 
[C4mim][N(CN)2] +  Na2SO4; 
Lane 5 (C) and Lane 6 (D): Top and bottom phases, respectively, of the ATPS constituted by 
[C4mim][N(CN)2] + Na2SO4; 
Lane 7 (E) and Lane 8 (E): Top and bottom phases, respectively, of the ATPS constituted by 
[C4mim][N(CN)2] + Na2SO4. 
 
 
3.3.4. Simulation of a countercurrent chromatography process 
The results obtained so far suggest that β-livetin can be partially and selectively 
removed from the phase containing IgY. Therefore, and trying to simulate a 
“countercurrent chromatography” approach three successive extractions wherein the 
bottom phase, the salt-rich phase, was “recycled” and reused were carried out.  
In the three cycles and after a proper separation of the phases it was investigated the 
protein profile in each ATPS. The results obtained are shown in Figure 35. In the first 
ATPS almost all β-livetin was removed because only in the top phase of the first ATPS, 
lane (A), is evident the band corresponding to β-livetin. In the second and third ATPS, β-
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livetin was completely removed because in the respective top phases, lanes (B) and (C), no 
longer appears the band corresponding to β-livetin. 
The absence of any band in sample (D), that corresponds to the bottom phase of the 
third ATPS, and where it was expected the single band of IgY may be explained again by a 
higher sample dilution than really necessary due to the point mixture chosen. However, the 
presence of IgY in this phase is assured in the top phase, lane (C), because although the 
presence of this protein is not detected it was not visually observed any denaturation 
behavior between the three cycles. 
 
 
Figure 34 - SDS-PAGE of a gel loaded with 0.5 µg of protein/well, stained with Coomassie blue. 
Lane 1 (Std): Standard molecular weights; 
Lane 2 (Pure IgY): Commercial and pure IgY from chicken egg yolk from by Sigma-
Aldrich®; 
Lane 3 (A): Top phase of the 1
st
 ATPS. 
 Lane 4 (B): Top phase of the 2
nd
 ATPS.  
Lane 5 (C): Top phase of the 3
rd
 ATPS.  
Lane 6 (D): Bottom phase of the 3
rd
 ATPS.  
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3.4. Conclusions 
In this work novel phase diagrams for ATPS composed of PEG 200, PEG 300, PEG 
400 and PEG 600, sodium sulfate and water, as well as constituted by PEG , sodium 
sulfate, water and different ILs were determined. Moreover, the corresponding TLs and 
TLLs were also ascertained. The diversity of PEGs and ILs investigated leads to different 
abilities in the liquid-liquid demixing behavior. In general, PEGs of higher hydrophobicity 
or higher molecular weight lead to an improved ability for phase separation. On the other 
hand, with a common PEG and with different ILs at two concentrations, the phase 
separation is favored by ILs of higher hydrophobicity, or less affinity to hydrogen-bond 
with water, or with the increased amount of IL in the medium. After the proper 
characterization of these ATPS they were further used in the purification of IgY from egg 
yolk. 
For the first time, it was studied the use of ATPS to purify IgY from aqueous 
solutions of raw egg yolk. Amongst the several systems, the most promising results were 
obtained with ILs constituted by the anion [N(CN)2]
-
. In the ATPS formed by IL + Na2SO4 
it was verified that lower concentrations of IL provide enhanced selective separations. 
Huge advances were obtained in this work allowing to conclude that the use of ILs as 
adjuvants in conventional PEG-salt systems provide an improvement for the purification of 
IgY from egg yolk in what concerns the development of a more benign and cost-effective 
process. Although the complete purification was not achieved in a single-step,  it was 
observed a preferential partitioning of β-livetin for the top phase whereas the IgY was 
mainly retained in the bottom phase. In this context, the complete purification of the Ig 
seems plausible by applying consecutive separation steps to completely remove β-livetin 
from the phase containing IgY. To this end, it was used a three-cycle process to simulate a 
“countercurrent chromatography” approach reveling that the major contaminant was 
completely removed from the phase containing the immunoglobulin. The use of 
countercurrent chromatography is thus a viable and effective option that should be 
explored as a future strategy. 
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4. Final remarks  
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4.1. General conclusions and future work  
In this work, it was studied a new method to purify IgY from raw egg yolk. Several 
ATPS were studied, either composed of polymers and salts, polymers, salts and ILs as 
adjuvants or of ILs and salts. Since the purification of IgY was not achieved in a single-
step procedure further investigations are still required. 
Based on the results gathered in this work the next step should involve the 
application of the improved system in countercurrent chromatography to completely purify 
IgY. Moreover, and after the complete purification of IgY, the recuperation step from the 
salt-rich phase should be further addressed, as well as the recycling nature of the ATPS 
used. Additional investigations on the protein stability and activity should also be 
conducted to ascertain on the effects of the phase-forming components through IgY. Given 
the remarkable results obtained, the use of the investigated ATPS is also highly 
recommended in the purification of other biopharmaceuticals, such as antibodies from 
mammal sources, nucleic acids and recombinant proteins. 
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Appendix B: calibration curves 
B. 1. Calibration curve for the quantification of the total amount of 
proteins 
Figure B 1 depicts the calibration curve (absorbance vs. concentration of total 
amount of protein). The calibration curve was made with BSA. 
 
 
 
Figure B 1 - Calibration curve for total amount of protein at λ = 280 nm. 
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Appendix A: experimental binodal 
curves 
 
 
  
A.1. Experimental binodal data for systems composed of PEG 600 + 
Na2SO4 + H2O and PEG 600 + Na2SO4 + [C4mim]Cl + H2O 
The phase diagrams of the ternary systems composed of PEG 600 + Na2SO4 + H2O 
obtained in this wok and the one reported in literature are shown in Figure A 1. 
 
 
Figure A 1 - Phase diagrams for the ternary systems composed of PEG 600 + Na2SO4 + H2O at  
298 K: this work (); literature data () [12]. 
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The phase diagrams of the ternary systems composed of PEG 600 + Na2SO4 + 
[C4mim]Cl + H2O obtained in this work and reported in literature are shown in Figure A 2. 
 
 
Figure A 2 - Phase diagrams for the quaternary systems composed of PEG 600 + Na2SO4 + [C4mim]Cl + 
H2O at 298 K: this work (); literature data () [12]. 
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The experimental weight fraction data for the phase diagrams of the systems 
composed of PEG + Na2SO4 + H2O and PEG + Na2SO4 + IL + H2O are presented in Table 
A 1 to Table A 5. 
 
Table A 1 - Experimental weight fraction data for the systems composed of PEG  (1) + Na2SO4 (2) + H2O (3) 
at 298 K and atmospheric pressure. 
Mw of PEG 
 
Mw of PEG 
600 g·mol
-1
 
 
400 g·mol
-1
 
100 w1 
 
100 w2 
 
100 w1 
 
100 w2 
 
100 w1 
 
100 w2 
38.638 
 
2.999 
 
14.277 
 
13.183 
 
26.818 
 
6.449 
36.938 
 
3.318 
 
16.214 
 
12.090 
 
27.107 
 
6.334 
34.781 
 
3.860 
 
17.454 
 
11.213 
 
27.900 
 
6.154 
33.625 
 
4.096 
 
17.850 
 
10.902 
 
28.038 
 
6.017 
32.490 
 
4.318 
 
18.529 
 
10.540 
 
28.132 
 
5.924 
30.678 
 
4.826 
 
19.287 
 
10.194 
 
28.624 
 
5.793 
28.745 
 
5.434 
 
19.811 
 
9.898 
 
28.801 
 
5.701 
27.459 
 
5.802 
 
20.288 
 
9.608 
 
29.462 
 
5.570 
26.298 
 
6.176 
 
20.865 
 
9.319 
 
29.792 
 
5.378 
24.996 
 
6.631 
 
21.390 
 
9.074 
 
30.334 
 
5.266 
23.249 
 
7.266 
 
21.784 
 
8.835 
 
30.358 
 
5.190 
21.583 
 
7.910 
 
22.042 
 
8.637 
 
30.499 
 
5.112 
20.689 
 
8.260 
 
22.611 
 
8.459 
 
30.876 
 
5.014 
18.997 
 
8.993 
 
23.274 
 
8.057 
 
31.029 
 
4.937 
17.622 
 
9.581 
 
23.548 
 
7.881 
 
31.507 
 
4.839 
16.718 
 
9.975 
 
24026 
 
7.768 
 
32.379 
 
4.716 
15.223 
 
10.670 
 
24.480 
 
7.475 
 
32.686 
 
4.606 
14.468 
 
10.998 
 
24.837 
 
7.326 
 
33.066 
 
4.517 
13.299 
 
11.546 
 
25.536 
 
7.094 
 
33.475 
 
4.429 
12.624 
 
11.861 
 
25.647 
 
6.913 
 
33.794 
 
4.278 
11.846 
 
12.226 
 
25.968 
 
6.780 
 
34.114 
 
4.203 
    
26.236 
 
6.669 
 
34.406 
 
4.123 
    
26.632 
 
6.579 
    
 
 
Table A 2 - Experimental weight fraction data for the systems composed of PEG (1) + Na2SO4 (2) +  
H2O (3) at 298 K and atmospheric pressure. 
Mw of PEG 
 
Mw of PEG 
300 g·mol
-1
 
 
200 g·mol
-1
 
100 w1 
 
100 w2 
 
100 w1 
 
100 w2 
 
100 w1 
 
100 w2 
13.730 
 
14.987 
 
29.723 
 
6.420 
 
21.541 
 
13.536 
14.620 
 
14.407 
 
29.982 
 
6.318 
 
22.179 
 
12.942 
15.659 
 
13.893 
 
30.169 
 
6.203 
 
22.783 
 
12.496 
16.612 
 
13.391 
 
30.367 
 
6.093 
 
24.400 
 
11.840 
17.290 
 
12.895 
 
30.696 
 
6.005 
 
24.885 
 
11.466 
18.002 
 
12.456 
 
31.375 
 
5.860 
 
25.017 
 
11.097 
18.251 
 
11.839 
 
31.823 
 
5.689 
 
25.554 
 
10.770 
19.215 
 
11.606 
 
32.565 
 
5.474 
 
26.769 
 
10.289 
19.719 
 
11.252 
 
32.642 
 
5.391 
 
26.940 
 
10.012 
20.290 
 
10.854 
 
33.194 
 
5.270 
 
27.383 
 
9.735 
21.033 
 
10.635 
 
33.836 
 
5.071 
 
27.928 
 
9.514 
21.524 
 
10.329 
 
34.413 
 
4.900 
 
28.782 
 
9.186 
22.051 
 
10.044 
 
35.170 
 
4.706 
 
29.674 
 
8.832 
22.452 
 
9.717 
 
35.288 
 
4.640 
 
30.283 
 
8.434 
23.036 
 
9.476 
 
35.873 
 
4.487 
 
30.474 
 
8.246 
23.512 
 
9.249 
 
36.443 
 
4.308 
 
31.387 
 
7.939 
23.970 
 
9.003 
     
31.718 
 
7.778 
24.063 
 
8.705 
     
31.918 
 
7.640 
24.635 
 
8.558 
     
32.516 
 
7.407 
25.045 
 
8.395 
     
33.083 
 
7.173 
25.330 
 
8.232 
     
33.738 
 
6.966 
25.740 
 
8.045 
     
34.197 
 
6.782 
26.111 
 
7.871 
     
34.680 
 
6.592 
26.433 
 
7.756 
     
35.392 
 
6.326 
26.762 
 
7.570 
     
35.842 
 
6.168 
27.106 
 
7.406 
     
35.866 
 
6.089 
28.028 
 
7.171 
     
36.180 
 
5.952 
28.337 
 
7.043 
     
36.651 
 
5.800 
28.597 
 
6.898 
     
37.873 
 
5.509 
28.857 
 
6.773 
     
38.840 
 
5.106 
29.148 
 
6.646 
     
39.238 
 
4.994 
29.424 
 
6.520 
     
40.164 
 
4.839 
  
Table A 3 - Experimental weight fraction data for the systems composed of PEG (1) + Na2SO4 (2) + H2O (3) 
+ 5 wt % IL at 298 K and atmospheric pressure. 
[C4mim]Cl [C4mim][TOS] 
 
[C4mim][SCN] 
100 w1 100 w2 100 w1 
 
100 w2 
 
100 w1 
 
100 w2 
8.703 14.944 9.707 
 
14.725 
 
14.005 
 
11.253 
10.001 14.153 10.435 
 
14.017 
 
15.307 
 
10.500 
10.461 13.425 11.945 
 
13.199 
 
17.370 
 
9.696 
11.895 12.753 13.431 
 
12.604 
 
17.744 
 
9.368 
12.470 12.129 13.995 
 
12.244 
 
18.887 
 
9.012 
13.133 11.846 14.531 
 
11.899 
 
20.107 
 
8.453 
13.700 11.446 15.111 
 
11.559 
 
20.898 
 
8.064 
14.058 11.141 15.758 
 
11.233 
 
21.263 
 
7.883 
14.676 10.817 16.308 
 
10.944 
 
22.207 
 
7.614 
15.177 10.583 17.437 
 
10.558 
 
23.171 
 
7.209 
16.296 10.200 17.864 
 
10.283 
 
24.778 
 
6.636 
17.327 9.798 18.266 
 
10.048 
 
26.060 
 
6.151 
17.389 9.425 18.655 
 
9.817 
 
28.468 
 
5.367 
18.354 8.878 19.049 
 
9.604 
 
29.614 
 
5.079 
19.056 8.663 19.896 
 
9.269 
 
30.312 
 
4.841 
19.467 8.329 20.219 
 
9.070 
 
31.300 
 
4.595 
20.076 8.098 20.502 
 
8.893 
 
32.084 
 
4.388 
20.737 7.740 21.311 
 
8.631 
 
33.574 
 
4.052 
21.332 7.579 21.769 
 
8.275 
 
34.790 
 
3.764 
21.778 7.407 22.473 
 
8.030 
 
35.894 
 
3.558 
22.012 7.238 22.715 
 
7.880 
 
37.195 
 
3.299 
22.307 7.073 23.464 
 
7.642 
 
38.506 
 
3.069 
22.752 6.853 24.302 
 
7.281 
 
40.485 
 
2.760 
23.599 6.498 24.996 
 
6.991 
 
42.293 
 
2.504 
24.023 6.388 25.699 
 
6.701 
    
24.343 6.191 26.464 
 
6.416 
    
24.909 6.014 27.430 
 
6.119 
    
25.336 5.832 28.861 
 
5.634 
    
25.658 5.739 29.878 
 
5.306 
    
26.390 5.482 30.940 
 
4.970 
    
26.661 5.387 32.153 
 
4.696 
    
  
Table A 4 - Experimental weight fraction data for the systems composed of PEG (1) + Na2SO4 (2) + H2O (3) 
+ IL at 298 K and atmospheric pressure. 
[C4mim][CH3CO2] 
 
[C4mim][N(CN)2] 
100 w1 
 
100 w2 
 
100 w1 
 
100 w2 
 
100 w1 
 
100 w2 
16.184 
 
13.358 
 
10.241 
 
13.164 
 
27.117 
 
5.785 
16.780 
 
12.907 
 
11.040 
 
12.696 
 
27.570 
 
5.642 
17.293 
 
12.400 
 
11.857 
 
12.278 
 
27.987 
 
5.520 
17.661 
 
12.027 
 
13.432 
 
11.715 
 
28.420 
 
5.387 
18.778 
 
11.450 
 
14.204 
 
11.297 
 
28.753 
 
5.260 
19.190 
 
11.125 
 
16.087 
 
10.435 
 
29.101 
 
5.148 
19.504 
 
10.779 
 
16.608 
 
10.141 
 
29.716 
 
4.996 
20.490 
 
10.343 
 
17.080 
 
9.862 
 
30.405 
 
4.792 
20.917 
 
10.051 
 
17.509 
 
9.598 
 
31.417 
 
4.545 
21.802 
 
9.654 
 
18.621 
 
9.227 
 
32.169 
 
4.339 
21.907 
 
9.383 
 
19.021 
 
8.984 
 
32.801 
 
4.190 
22.569 
 
9.038 
 
19.408 
 
8.767 
 
34.124 
 
3.894 
23.302 
 
8.720 
 
20.330 
 
8.473 
    
24.136 
 
8.174 
 
20.649 
 
8.286 
    
25.232 
 
7.653 
 
20.991 
 
8.104 
    
25.796 
 
7.402 
 
21.689 
 
7.859 
    
26.398 
 
7.164 
 
22.305 
 
7.555 
    
26.960 
 
6.950 
 
22.574 
 
7.409 
    
27.434 
 
6.757 
 
23.352 
 
7.166 
    
27.918 
 
6.571 
 
23.563 
 
7.020 
    
28.671 
 
6.328 
 
24.130 
 
6.812 
    
29.043 
 
6.153 
 
24.787 
 
6.606 
    
30.419 
 
5.740 
 
25.222 
 
6.439 
    
31.239 
 
5.428 
 
25.720 
 
6.276 
    
32.146 
 
5.137 
 
25.923 
 
6.173 
    
33.605 
 
4.716 
 
26.454 
 
6.025 
    
39.029 
 
3.486 
 
26.608 
 
5.922 
    
 
 
 
Table A 5 - Experimental weight fraction data for the systems composed of PEG (1) + Na2SO4 (2) + H2O (3) 
+ IL at 298 K and atmospheric pressure. 
[C4mim][N(CN)2]  
[C4mpy][N(CN)2]  
[C2mim][N(CN)2] 
100 w1  
100 w2  
100 w1  
100 w2  
100 w1  
100 w2 
9.895 
 
10.200 
 
19.754 
 
7.373 
 
11.151 
 
11.567 
12.298 
 
9.397 
 
20.712 
 
6.514 
 
12.791 
 
10.896 
13.668 
 
8.871 
 
21.827 
 
6.083 
 
13.433 
 
10.464 
15.440 
 
8.159 
 
23.197 
 
5.674 
 
14.781 
 
9.893 
16.637 
 
7.738 
 
23.883 
 
5.377 
 
15.242 
 
9.570 
18.103 
 
7.197 
 
25.703 
 
4.820 
 
16.421 
 
9.095 
19.455 
 
6.788 
 
26.643 
 
4.599 
 
18.511 
 
8.241 
19.994 
 
6.481 
 
27.348 
 
4.383 
 
18.864 
 
7.973 
21.084 
 
6.158 
 
28.345 
 
4.129 
 
19.573 
 
7.636 
21.916 
 
5.873 
 
31.542 
 
3.616 
 
21.486 
 
6.968 
22.577 
 
5.637 
 
34.297 
 
3.335 
 
22.817 
 
6.433 
23.276 
 
5.392 
 
35.309 
 
3.136 
 
23.271 
 
6.220 
23.812 
 
5.230 
 
36.088 
 
2.971 
 
24.718 
 
5.817 
25.045 
 
4.943 
 
36.848 
 
2.821 
 
25.865 
 
5.453 
26.117 
 
4.696 
 
37.924 
 
2.641 
 
26.773 
 
5.172 
27.060 
 
4.425 
 
39.005 
 
2.471 
 
27.744 
 
4.923 
28.598 
 
4.100 
 
39.985 
 
2.330 
 
28.662 
 
4.712 
29.813 
 
3.802 
 
40.927 
 
2.201 
 
29.528 
 
4.512 
31.010 
 
3.603 
 
41.748 
 
2.095 
 
30.438 
 
4.273 
32.766 
 
3.296 
 
42.734 
 
1.973 
 
31.822 
 
3.974 
34.068 
 
3.104 
 
44.269 
 
1.802 
 
33.192 
 
3.685 
35.453 
 
2.852 
 
45.987 
 
1.639 
 
36.081 
 
3.204 
37.653 
 
2.582 
     
37.267 
 
3.004 
        
40.271 
 
2.594 
  
The experimental weight fraction data for the phase diagrams of the systems 
composed of PEG + Na2SO4 + PBS and PEG + Na2SO4 + IL + PBS are presented in Table 
A 6 to Table A 7. 
 
Table A 6 - Experimental weight fraction data for the systems composed of PEG (1) + Na2SO4 (2) + PBS (3) 
at 298 K and atmospheric pressure. 
100 w1  
100 w2  
100 w1  
100 w2 
16.181 
 
13.314 
 
31.159 
 
5.471 
16.536 
 
12.794 
 
31.778 
 
5.278 
17.593 
 
12.166 
 
32.280 
 
5.098 
18.628 
 
11.600 
 
32.845 
 
4.939 
19.492 
 
11.006 
 
33.501 
 
4.705 
20.779 
 
10.350 
 
33.783 
 
4.597 
21.978 
 
9.774 
 
34.404 
 
4.438 
22.755 
 
9.331 
 
35.084 
 
4.218 
23.725 
 
8.937 
 
35.535 
 
4.095 
24.050 
 
8.585 
 
35.866 
 
3.990 
24.695 
 
8.236 
 
36.180 
 
3.895 
25.089 
 
7.948 
 
36.554 
 
3.806 
25.610 
 
7.713 
 
36.967 
 
3.699 
26.329 
 
7.389 
 
37.672 
 
3.527 
27.081 
 
7.114 
 
37.706 
 
3.441 
27.609 
 
6.862 
 
38.422 
 
3.317 
28.234 
 
6.634 
 
39.012 
 
3.190 
28.496 
 
6.456 
 
39.482 
 
3.085 
29.014 
 
6.248 
 
40.021 
 
2.985 
29.646 
 
6.018 
 
40.716 
 
2.850 
29.932 
 
5.890 
 
41.105 
 
2.776 
30.469 
 
5.697 
 
41.811 
 
2.632 
 
 
Table A 7 - Experimental weight fraction data for the systems composed of PEG (1) + Na2SO4 (2) + PBS (3) 
+ IL at 298 K and atmospheric pressure. 
[C4mim][N(CN)2] 
100 w1  
100 w2  
100 w1  
100 w2 
1.292 
 
16.688 
 
22.948 
 
7.364 
3.94 
 
15.523 
 
23.870 
 
6.970 
5.113 
 
14.800 
 
24.002 
 
6.839 
7.612 
 
13.831 
 
24.552 
 
6.645 
8.463 
 
13.324 
 
24.934 
 
6.446 
10.697 
 
12.496 
 
26.436 
 
6.231 
12.173 
 
11.816 
 
27.293 
 
5.930 
12.847 
 
11.459 
 
27.470 
 
5.771 
16.586 
 
10.475 
 
28.057 
 
5.589 
17.171 
 
10.139 
 
28.439 
 
5.445 
17.761 
 
9.866 
 
28.699 
 
5.329 
18.054 
 
9.599 
 
29.361 
 
5.134 
19.490 
 
9.040 
 
29.949 
 
4.917 
19.690 
 
8.773 
 
30.496 
 
4.774 
20.535 
 
8.453 
 
30.776 
 
4.633 
21.071 
 
8.150 
 
30.481 
 
4.474 
21.739 
 
7.876 
 
30.872 
 
4.351 
22.414 
 
7.600 
    
 
